| Vitamin A and Zinc Supplementation Among Pregnant Women to Prevent Placental Malaria: A Randomized, Double-Blind, Placebo-Controlled Trial in Tanzania 2017 · zinc group · Pregnant women in their first trimester, primigravid or secundigravid, HIV-negative | 25 mg | — | 625 |
| The effect of zinc supplementation on pregnancy outcomes: a double-blind, randomised controlled trial, Egypt 2015 · Zn alone group · Pregnant women aged 20–45 years with low serum zinc for gestational age | 30 mg | — | 225 |
| Effect of antenatal zinc supplementation on impetigo in infants in Bangladesh 2012 · zinc group · Pregnant Bangladeshi women whose infants were followed up to 6 months of age | 30 mg | — | 199 |
| The effects of zinc supplementation on serum zinc, alkaline phosphatase activity and fracture healing of bones 2008 · cases · Patients with traumatic bone fractures | 50 mg | 60 days | 30 |
| Simultaneous zinc and vitamin A supplementation in Bangladeshi children: randomised double blind controlled trial 2001 · zinc · Children aged 12–35 months living in urban slums of Dhaka, Bangladesh | 20 mg | 2 weeks | — |
| Zinc for severe pneumonia in very young children: double-blind placebo-controlled trial 2004 · elemental zinc · Children aged 2–23 months with severe pneumonia | 20 mg | — | — |
| Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress 2007 · zinc-supplemented group · Healthy adults aged 55–87 years, both sexes | 45 mg | 1 year | — |
| Effect of zinc supplementation on respiratory tract infections in children with cystic fibrosis 2008 · zinc-treated patients · children aged 7–18 years with cystic fibrosis | 30 mg | 1 year | — |
| A double-blind trial of zinc supplementation in pregnancy 1991 · zinc supplement · Pregnant women at risk of delivering a small-for-gestational-age baby, during the last two trimesters | 22.5 mg | — | — |
| No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No. 18 2019 · Lower-zinc-dose group · Adults with bilateral large drusen or late AMD in one eye and large drusen in the fellow eye | 25 mg | 5 years | — |
| No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No. 18 2019 · Lower zinc dose plus elimination of beta-carotene · Adults with bilateral large drusen or late AMD in one eye and large drusen in the fellow eye | 25 mg | 5 years | — |
| Efficacy of Adjunctive Zinc in Improving the Treatment Outcomes in Hospitalized Children with Pneumonia: A Randomized Controlled Trial 2020 · zinc group · Hospitalized children with pneumonia | 30 mg | — | — |
| The effect of zinc supplementation on pregnancy outcome 1995 · zinc supplement group · Pregnant African-American women with relatively low plasma zinc concentrations, randomized at 19 weeks' gestational age; otherwise healthy | 25 mg | — | — |
| The impact of zinc supplementation on Schistosoma mansoni reinfection rate and intensities: a randomized, controlled trial among rural Zimbabwean schoolchildren 1997 · zinc 30 mg · Rural Zimbabwean schoolchildren aged 11–17 years, boys and girls | 30 mg | 1 year | — |
| The impact of zinc supplementation on Schistosoma mansoni reinfection rate and intensities: a randomized, controlled trial among rural Zimbabwean schoolchildren 1997 · zinc 50 mg · Rural Zimbabwean schoolchildren aged 11–17 years, boys and girls | 50 mg | 1 year | — |
| Effect of daily zinc supplementation on child mortality in southern Nepal: a community-based, cluster randomised, placebo-controlled trial 2007 · zinc · Children aged 1–35 months in rural southern Nepal | 10 mg | — | 20,968 |
| Effect of weekly zinc supplements on incidence of pneumonia and diarrhoea in children younger than 2 years in an urban, low-income population in Bangladesh: randomised controlled trial 2005 · zinc · Children aged 60 days to 12 months in a poor, urban population in Bangladesh | 10 mg | 1 year | 809 |
| Zinc as adjunct treatment in infants aged between 7 and 120 days with probable serious bacterial infection: a randomised, double-blind, placebo-controlled trial 2012 · zinc · Infants aged 7–120 days with probable serious bacterial infection | 10 mg | — | 352 |
| Effect of prenatal zinc supplementation on birthweight 2009 · Iron-zinc group · Pregnant women recruited by 16 weeks’ gestation in Ghana; age range 16–44 years; no stated diagnosed condition, with women taking other zinc supplements or with severe anaemia excluded. | 20 mg | — | 299 |
| Zinc supplementation reduces the incidence of acute lower respiratory infections in infants and preschool children: a double-blind, controlled trial 1998 · zinc · Children aged 6 to 35 months | 10 mg | 180 days | 298 |
| The influence of zinc supplementation on morbidity due to Plasmodium falciparum: a randomized trial in preschool children in Papua New Guinea 2000 · zinc · Preschool children aged 6 to 60 months living in a malaria-endemic region of Papua New Guinea | 10 mg | 46 weeks | 136 |
| Zinc for infection prevention in children with sickle cell anemia: a randomized double-blind placebo-controlled trial 2023 · Zinc · Ugandan children aged 1.00–4.99 years with sickle cell anemia (HbSS), both sexes | 10 mg | 1 year | 124 |
| The prophylactic and therapeutic effectiveness of zinc sulphate on common cold in children 2006 · zinc group · healthy children; age and sex not reported | 15 mg | 213 days | 100 |
| The efficacy of zinc supplementation in young children with acute lower respiratory infections: a randomized double-blind controlled trial 2013 · zinc group · Children up to 5 years old with acute lower respiratory infections living in a zinc-poor population | 10 mg | 60 days | 48 |
| Efficacy of zinc supplements in reducing relapses in steroid-sensitive nephrotic syndrome 2009 · zinc · Children aged 1–16 years with steroid-sensitive nephrotic syndrome, including frequent and infrequent relapsers | 10 mg | 1 year | 40 |
| Zinc adjuvant treatment in SARS-CoV-2: A randomized clinical trial 2025 · zinc group · Adults hospitalized with confirmed COVID-19 | 90 mg | 2 weeks | 35 |
| Improved estimation of glomerular filtration rate by serum cystatin C in preventing contrast induced nephropathy by N-acetylcysteine or zinc--preliminary results 2008 · Zinc (Zn) · Patients with moderately impaired kidney function receiving low-osmolar, non-ionic contrast media | 60 mg | 1 day | 18 |
| Zinc supplementation decreases oxidative stress, incidence of infection, and generation of inflammatory cytokines in sickle cell disease patients 2008 · zinc-supplemented group · Adults with sickle-cell disease | 75 mg | 90 days | 18 |
| Effect of zinc supplementation on malaria and other causes of morbidity in west African children: randomised double blind placebo controlled trial 2001 · zinc group · Young children living in a malaria-endemic area of rural Burkina Faso; exact age range not stated | 12.5 mg | 26 weeks | — |
| Effects of iron and zinc supplementation in Indonesian infants on micronutrient status and growth 2001 · zinc · Indonesian infants, 4 months of age | 10 mg | 26 weeks | — |
| Impact of zinc supplementation on diarrhoeal morbidity in rural children of West Bengal, India 2003 · daily zinc group · children aged 6–41 months in rural West Bengal, India | 10 mg | 16 weeks | — |
| Zinc modifies the association between nasopharyngeal Streptococcus pneumoniae carriage and risk of acute lower respiratory infection among young children in rural Nepal 2008 · zinc group · children aged 1–36 months living in a rural district in southern Nepal | 10 mg | — | — |
| Use of zinc supplements to reduce upper respiratory infections in United States Air Force Academy cadets 2009 · supplemented group · United States Air Force Academy cadets; age and sex not specified; no condition stated | 15 mg | 212 days | — |
| Effects of zinc supplementation on the survival of patients who received concomitant chemotherapy and radiotherapy for advanced nasopharyngeal carcinoma: follow-up of a double-blind randomized study with subgroup analysis 2009 · zinc supplement group · Patients with stage III or IV nasopharyngeal carcinoma receiving concomitant chemotherapy and radiotherapy | 75 mg | 60 days | — |
| The added benefit of zinc supplementation after zinc treatment of acute childhood diarrhoea: a randomized, double-blind field trial 2010 · zinc · Children aged 6–23 months with acute childhood diarrhoea, living in an urban slum in Dhaka, Bangladesh | 10 mg | 90 days | — |
| Protection against diarrhea associated with Giardia intestinalis Is lost with multi-nutrient supplementation: a study in Tanzanian children 2011 · zinc alone · Children aged 6–60 months in rural Tanzania, without the listed severe malnutrition or disease exclusions | 10 mg | 251 days | — |
| No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No. 18 2019 · Elimination of beta-carotene · Adults with bilateral large drusen or late AMD in one eye and large drusen in the fellow eye | 80 mg | 5 years | — |
| Lower-Dose Zinc for Childhood Diarrhea - A Randomized, Multicenter Trial 2020 · 20 mg · Children aged 6–59 months with acute diarrhea or dysentery in India or Tanzania | 20 mg | 2 weeks | 1,498 |
| Zinc supplementation in acute diarrhea is acceptable, does not interfere with oral rehydration, and reduces the use of other medications: a randomized trial in five countries 2006 · zinc group · Children aged 2 to 59 months with acute watery diarrhea | 20 mg | 2 weeks | 1,010 |
| Effects of therapeutic zinc supplementation for diarrhea and two preventive zinc supplementation regimens on the incidence and duration of diarrhea and acute respiratory tract infections in rural Laotian children: A randomized controlled trial 2020 · Therapeutic zinc (TZ) supplementation group · Children aged 6–23 months in rural Laos, with diarrhea episodes treated during follow-up | 20 mg | 40 weeks | 851 |
| Effects of Daily Zinc, Daily Multiple Micronutrient Powder, or Therapeutic Zinc Supplementation for Diarrhea Prevention on Physical Growth, Anemia, and Micronutrient Status in Rural Laotian Children: A Randomized Controlled Trial 2019 · Therapeutic zinc supplementation group · Children aged 6–23 months at enrollment in rural Laos, given therapeutic supplementation when they had diarrhea. | 20 mg | 36 weeks | 764 |
| Zinc supplementation during pregnancy and effects on growth and morbidity in low birthweight infants: a randomised placebo controlled trial 2001 · maternal zinc group · Bangladeshi pregnant women whose infants were followed for growth and morbidity | 30 mg | — | 199 |
| Randomized, community-based trial of the effect of zinc supplementation, with and without other micronutrients, on the duration of persistent childhood diarrhea in Lima, Peru 1999 · group Z · Children aged 6 to 36 months with persistent diarrhea (at least 14 days) | 20 mg | 2 weeks | 139 |
| Short-course prophylactic zinc supplementation for diarrhea morbidity in infants of 6 to 11 months 2013 · zinc group · Infants aged 6 to 11 months in an urban resettlement colony in Delhi, India | 20 mg | 2 weeks | 134 |
| Zinc adjunct therapy reduces case fatality in severe childhood pneumonia: a randomized double blind placebo-controlled trial 2012 · Zinc group, children aged 12 to 59 months · Children aged 12 to 59 months admitted with severe pneumonia | 20 mg | 7 days | 100 |
| Zinc supplementation in children with cholera in Bangladesh: randomised controlled trial 2008 · zinc group · Children aged 3–14 years with watery diarrhoea and cholera confirmed by stool culture | 30 mg | — | 90 |
| A randomised controlled trial of oral zinc sulphate for primary dysmenorrhoea in adolescent females 2015 · intervention group (zinc) · Adolescent females with primary dysmenorrhoea | 50 mg | 90 days | 60 |
| Efficacy of zinc supplementation for the treatment of dysmenorrhoea: a double-blind randomised controlled trial 2023 · zinc sulfate group (Group A) · Female senior secondary students aged 13–21 years with primary dysmenorrhoea | 40 mg | — | 52 |
| A randomized, prospective, placebo-controlled clinical trial of a novel zinc-monocysteine compound in age-related macular degeneration 2008 · ZMC group · People with dry age-related macular degeneration, best-corrected visual acuity 20/25 to 20/70, macular drusen, and pigment changes; age range and sex not reported | 50 mg | 26 weeks | 40 |
| A randomized, placebo-controlled trial of zinc supplementation during pregnancy for the prevention of stunting: analysis of maternal serum zinc, cord blood osteocalcin and neonatal birth length 2021 · supplementation group · Pregnant women in their second or third trimester and their newborns | 20 mg | 12 weeks | 35 |
| Efficacy of Zinc Supplement in Minimal hepatic Encephalopathy: A prospective, Randomized Controlled Study (Zinc-MHE Trial) 2021 · Zinc group · Adults aged 18–75 with cirrhosis and minimal hepatic encephalopathy | 45 mg | 12 weeks | 35 |
| Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study 2009 · zinc supplementation · Adults aged 18–55 with unipolar major depression, including antidepressant treatment-resistant patients | 25 mg | 12 weeks | 30 |
| Effects of low dose zinc supplementation on biochemical markers in non-alcoholic cirrhosis: a randomized clinical trial 2012 · interventional group · Adults with non-alcoholic cirrhosis | 50 mg | 90 days | 30 |
| The effects of zinc supplementation on wound healing and metabolic status in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial 2017 · zinc supplementation · Adults aged 40–85 years with grade 3 diabetic foot ulcer | 50 mg | 12 weeks | 30 |
| The role of zinc in the treatment of tinnitus 2003 · zinc group · Adults with tinnitus and no known pathologic conditions of the ear, nose, or throat; mean age 51.2 years | 50 mg | 60 days | 28 |
| A zinc-containing compound, Polaprezinc, is effective for patients with taste disorders: randomized, double-blind, placebo-controlled, multi-center study 2009 · 34 mg zinc group · Patients with idiopathic taste disorders, including patients with low serum zinc | 34 mg | 12 weeks | 26 |
| Effects of Zinc Supplementation on Endocrine Outcomes in Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial 2016 · group 1 · Women aged 18–40 with polycystic ovary syndrome diagnosed according to Rotterdam criteria | 50 mg | 8 weeks | 24 |
| Effects of zinc supplementation on efficacy of antidepressant therapy, inflammatory cytokines, and brain-derived neurotrophic factor in patients with major depression 2014 · zinc-supplemented group · Men and women aged 18–55 years with DSM-IV major depression | 25 mg | 12 weeks | 20 |
| Effects of Zinc Supplementation on Inflammatory and Cognitive Parameters in Middle-Aged Women with Overweight or Obesity 2023 · zinc group · Women aged 40–60 years with overweight or obesity | 30 mg | 12 weeks | 20 |
| Supplementary zinc and vitamin D in management of symptomatic oral lichen planus: a three-arm randomized clinical trial 2025 · Group II (TA + Zn) · Adults with symptomatic atrophic, erosive, or bullous oral lichen planus; age and sex ranges not specified | 50 mg | 8 weeks | 14 |
| Zinc for attention-deficit/hyperactivity disorder: placebo-controlled double-blind pilot trial alone and combined with amphetamine 2011 · 15 mg b.i.d. zinc group · Children aged 6–14 with DSM-IV ADHD | 30 mg | 13 weeks | 8 |
| Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study 2003 · zinc supplementation · Patients who fulfilled DSM IV criteria for major (unipolar) depression; age and sex not stated. | 25 mg | 12 weeks | 6 |
| Zinc supplementation might potentiate the effect of vitamin A in restoring night vision in pregnant Nepalese women 2001 · zinc alone (zinc + placebo) · Pregnant women who developed night blindness; age not reported | 25 mg | 3 weeks | — |
| Effect of zinc supplementation started during diarrhoea on morbidity and mortality in Bangladeshi children: community randomised trial 2002 · intervention clusters · Children aged 3–59 months with diarrhoea | 20 mg | 2 weeks | — |
| Randomized, double-blind, placebo-controlled clinical trial of the efficacy of treatment with zinc or vitamin A in infants and young children with severe acute lower respiratory infection 2004 · zinc plus vitamin A placebo · Children aged 2–24 months hospitalized with severe acute lower respiratory infection | 20 mg | 5 days | — |
| Effect of vitamin A and zinc supplementation on the nutriture of children in Northeast Thailand 1992 · zinc · Children aged 6–13 years with marginal plasma retinol and zinc concentrations | 25 mg | 26 weeks | — |
| Taste acuity in response to zinc supplementation in older Europeans 2008 · 30 mg Zn/d group · Healthy adults aged 70–87 years recruited in Rome, Italy, or Grenoble, France | 30 mg | — | — |
| Does age affect the response to zinc therapy for diarrhoea in Bangladeshi infants? 2008 · Zinc intervention clusters · Children aged 3–47 months in rural Matlab, Bangladesh, who experienced a diarrhoea episode; includes the age-stratified infant groups | 20 mg | 2 weeks | — |
| Interaction of zinc or vitamin A supplementation and specific parasite infections on Mexican infants' growth: a randomized clinical trial 2009 · daily zinc supplement · Children aged 5–15 months | 20 mg | 1 year | — |
| Effects of zinc supplementation during pregnancy on pregnancy outcome in women with history of preterm delivery: a double-blind randomized, placebo-controlled trial 2010 · Zn supplemented group · Pregnant women aged 19–35 with a previous preterm delivery | 50 mg | — | — |
| Zinc monotherapy increases serum brain-derived neurotrophic factor (BDNF) levels and decreases depressive symptoms in overweight or obese subjects: a double-blind, randomized, placebo-controlled trial 2015 · zinc · Overweight or obese subjects | 30 mg | 12 weeks | — |
| Comparison of Preventive and Therapeutic Zinc Supplementation in Young Children in Burkina Faso: A Cluster-Randomized, Community-Based Trial 2016 · TZS · Children aged 6–30 months in rural Burkina Faso, receiving treatment for diarrhea | 20 mg | 48 weeks | — |
| The Effect of Zinc Lozenge on Postoperative Sore Throat: A Prospective Randomized, Double-Blinded, Placebo-Controlled Study 2018 · zinc group · Patients undergoing low- or moderate-risk surgery with endotracheal intubation; age and sex not specified | 40 mg | 1 day | — |
| The Effect of Zinc Gluconate Supplementation on Symptoms and Tongue Epithelium Regeneration in Non-psoriatic Patients with Migratory Glossitis 2018 · test group · Non-psoriatic patients with symptomatic migratory glossitis | 20 mg | 30 days | — |
| Effects of zinc, vitamin D, and their co-supplementation on mood, serum cortisol, and brain-derived neurotrophic factor in patients with obesity and mild to moderate depressive symptoms: A phase II, 12-wk, 2 × 2 factorial design, double-blind, randomized, placebo-controlled trial 2020 · Zinc group · Overweight or obese adults with depressive symptoms and BDI-II score ≥10; mean age 38.35 years | 30 mg | 12 weeks | — |
| Effect of zinc supplementation on quality of life and sleep quality in young women with premenstrual syndrome: a randomized, double-blind, placebo-controlled trial 2020 · zinc intervention group · Young women diagnosed with premenstrual syndrome | 30 mg | 12 weeks | — |
| Identifying risk factors for vomiting during diarrhea: A secondary analysis of a randomized trial of zinc supplementation 2025 · 20 mg zinc group · Children aged 6–59 months with an acute episode of diarrhea | 20 mg | — | — |
| Role of zinc supplementation in the rehabilitation of severely malnourished children 1993 · zinc group · children with severe protein-energy malnutrition undergoing rehabilitation | 40 mg | — | — |
| Zinc supplementation reduced morbidity, but neither zinc nor iron supplementation affected growth or body composition of Mexican preschoolers 1997 · zinc · Mexican preschool children in a rural community | 20 mg | 1 year | — |
| Effects of repletion with zinc and other micronutrients on neuropsychologic performance and growth of Chinese children 1998 · Z (zinc alone) · Children aged 6–9 years from low-income families in Chongqing, Qingdao, and Shanghai, China | 20 mg | 10 weeks | — |
| Positive impact of oral hydroxychloroquine and povidone-iodine throat spray for COVID-19 prophylaxis: An open-label randomized trial 2021 · Zinc & vitamin C · Men aged 21–60 living in a high-exposure migrant-worker dormitory in Singapore, without known COVID-19 at enrollment | 80 mg | 6 weeks | 634 |
| Effects of zinc supplementation in the prevention of respiratory tract infections and diarrheal disease in Colombian children: A 12-month randomised controlled trial 2016 · zinc supplementation group · Healthy children aged 6–12 months living in Bogota, Colombia | 5 mg | 1 year | 174 |
| Multicenter clinical trial of zinc acexamate in the prevention of nonsteroidal antiinflammatory drug induced gastroenteropathy. Spanish Study Group on NSAID Induced Gastroenteropathy Prevention 1994 · ZAC · Patients with rheumatic disease, a history of peptic ulcer or NSAID intolerance, and a need for NSAID treatment | 300 mg | 4 weeks | 141 |
| Randomized trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitis 2024 · A+Z · Adults aged 21 years or older with severe alcohol-associated hepatitis and MELD score 20–35 | 220 mg | 90 days | 74 |
| Efficacy of zinc sulfate supplement on febrile seizure recurrence prevention in children with normal serum zinc level: A randomised clinical trial 2015 · zinc sulfate group · Children aged 18–60 months with normal serum zinc and a first simple febrile seizure | 2 mg/kg | 26 weeks | 50 |
| Impact of zinc supplementation in malnourished children with acute watery diarrhoea 2000 · zinc supplemented group · Malnourished children with acute dehydrating diarrhoea; age and sex not specified | 177 mg/kg | — | 44 |
| Oral zinc sulphate in the treatment of recalcitrant viral warts: randomized placebo-controlled clinical trial 2002 · zinc-treated group · Patients with recalcitrant common, plantar or plane viral warts; all had more than 15 warts and low serum zinc. Age and sex were not reported. | 10 mg/kg | 60 days | 40 |
| Benefit of oral zinc supplementation as an adjunct to zidovudine (AZT) therapy against opportunistic infections in AIDS 1995 · Stage III zinc-treated group · People with stage III AIDS and generalized lymphadenopathy receiving AZT | 200 mg | 30 days | 17 |
| Benefit of oral zinc supplementation as an adjunct to zidovudine (AZT) therapy against opportunistic infections in AIDS 1995 · Stage IV subgroup C1 zinc-treated group · People with stage IV subgroup C1 AIDS receiving AZT | 200 mg | 30 days | 12 |
| A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8 2001 · Zinc · Adults aged 55–80 with age-related macular degeneration Categories 2–4 and visual acuity of 20/32 or better in at least one eye | 80 mg | 8 years | — |
| Effects of iron and zinc supplementation in Indonesian infants on micronutrient status and growth 2001 · iron + zinc · Indonesian infants, 4 months of age | 10 mg | 26 weeks | — |
| Impact of zinc supplementation on diarrhoeal morbidity in rural children of West Bengal, India 2003 · weekly zinc group · children aged 6–41 months in rural West Bengal, India | 7.14 mg | 16 weeks | — |
| Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13 2004 · zinc alone · Adults aged 55–81 years with AMD categories 2–4 and AREDS ocular eligibility | 80 mg | 339 weeks | — |
| Combined iron and zinc supplementation in infants improved iron and zinc status, but interactions reduced efficacy in a multicountry trial in southeast Asia 2007 · iron and zinc · Infants aged 4–6 months | 10 mg | 26 weeks | — |
| Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35 2013 · Zinc · Adults aged 55–80 with age-related macular degeneration (AREDS categories 1–4) | 80 mg | 339 weeks | — |
| No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38 2014 · zinc · Adults with intermediate age-related macular degeneration in one or both eyes or late age-related macular degeneration in one eye; mean age 69 years | 80 mg | 9 years | — |
| Response to AREDS supplements according to genetic factors: survival analysis approach using the eye as the unit of analysis 2016 · zinc · Adults aged 55 years and older with age-related macular degeneration; eyes with advanced disease at baseline and participants with no AMD in both eyes were excluded | 80 mg | 2409 days | — |
| The effect of probiotics and zinc supplementation on the immune response to oral rotavirus vaccine: A randomized, factorial design, placebo-controlled study among Indian infants 2018 · Probiotic placebo and zinc supplement · Infants enrolled at 35–41 days of age in India, without a medical condition precluding participation | 5 mg | 6 weeks | — |
| Short Term Oral Zinc Supplementation among Babies with Neonatal Sepsis for Reducing Mortality and Improving Outcome - A Double-Blind Randomized Controlled Trial 2018 · zinc group · Neonates with sepsis | 6 mg/kg | 10 days | — |
| The effect of zinc sulfate on prevention, incidence, and severity of mucositis in leukemia patients undergoing chemotherapy 2018 · experimental group · Leukemia patients undergoing chemotherapy; age and sex not stated | 150 mg | 2 weeks | — |
| Efficacy of zinc therapy in prevention of crisis in sickle cell anemia: a double blind, randomized controlled clinical trial 1995 · zinc sulphate capsules · Patients with sickle cell anaemia | 660 mg | 548 days | — |
| Effect of micronutrient supplementation on infection in institutionalized elderly subjects: a controlled trial 1997 · trace elements/zinc · Institutionalized elderly subjects in a geriatric center; low serum zinc and selenium were common at baseline | 20 mg | 2 years | — |
| Lower-Dose Zinc for Childhood Diarrhea - A Randomized, Multicenter Trial 2020 · 10 mg · Children aged 6–59 months with acute diarrhea or dysentery in India or Tanzania | 10 mg | 2 weeks | 1,498 |
| Effect of preventive supplementation with zinc and other micronutrients on non-malarial morbidity in Tanzanian pre-school children: a randomized trial 2012 · Zinc · Children aged 6–60 months with height-for-age z-score ≤−1.5 SD, in rural Tanzania | 10 mg | — | 153 |
| Randomized, community-based trial of the effect of zinc supplementation, with and without other micronutrients, on the duration of persistent childhood diarrhea in Lima, Peru 1999 · group Z+VM · Children aged 6 to 36 months with persistent diarrhea (at least 14 days) | 20 mg | 2 weeks | 137 |
| Randomized controlled trial of the effect of daily supplementation with zinc or multiple micronutrients on the morbidity, growth, and micronutrient status of young Peruvian children 2004 · Zn · Children aged 6–35 months with persistent diarrhea, supplemented after the diarrhea episode ended | 10 mg | 26 weeks | 81 |
| Zinc adjunct therapy reduces case fatality in severe childhood pneumonia: a randomized double blind placebo-controlled trial 2012 · Zinc group, children aged 6 to 11 months · Children aged 6 to 11 months admitted with severe pneumonia | 10 mg | 7 days | 76 |
| The Impact of Supplemental Antioxidants on Visual Function in Nonadvanced Age-Related Macular Degeneration: A Head-to-Head Randomized Clinical Trial 2017 · Group 2 · People with nonadvanced age-related macular degeneration; age and sex not stated | 25 mg | — | 61 |
| The Impact of Supplemental Antioxidants on Visual Function in Nonadvanced Age-Related Macular Degeneration: A Head-to-Head Randomized Clinical Trial 2017 · Group 1 · People with nonadvanced age-related macular degeneration; age and sex not stated | 25 mg | — | 60 |
| A randomized controlled trial of chelated zinc for prevention of the common cold in Thai school children 2013 · zinc group · Healthy school children aged 8–13 years | 15 mg | 90 days | 50 |
| Effect of zinc supplementation on growth in very low birth weight infants 2012 · zinc group · Very low birth weight infants born weighing less than 1500 g | 10 mg | 60 days | 46 |
| Impact of zinc supplementation on morbidity from diarrhea and respiratory infections among rural Guatemalan children 1997 · zinc supplementation · Guatemalan children aged 6 to 9 months | 10 mg | 30 weeks | 45 |
| Zinc supplementation improves the growth of stunted rural Guatemalan infants 1998 · zinc supplementation · Guatemalan infants aged 6–9 months | 10 mg | 30 weeks | 45 |
| Effect of zinc supplementation on cell-mediated immunity and lymphocyte subsets in preschool children 1997 · zinc group · Preschool children in an urban slum community | 10 mg | 120 days | 38 |
| Double-blind, placebo-controlled trial of zinc picolinate for taste disorders 2002 · zinc treatment group · Patients with an idiopathic zinc-deficiency taste disorder | 87 mg | 90 days | 37 |
| Investigating the effect of zinc supplementation on probability of relapse and mental health in patients with opioid use disorder undergoing methadone maintenance treatment 2023 · Intervention group · Adults over 18 with opioid use disorder receiving methadone maintenance treatment | 12 mg | 90 days | 34 |
| A zinc-containing compound, Polaprezinc, is effective for patients with taste disorders: randomized, double-blind, placebo-controlled, multi-center study 2009 · 68 mg zinc group · Patients with idiopathic taste disorders, including patients with low serum zinc | 68 mg | 12 weeks | 28 |
| A zinc-containing compound, Polaprezinc, is effective for patients with taste disorders: randomized, double-blind, placebo-controlled, multi-center study 2009 · 17 mg zinc group · Patients with idiopathic taste disorders, including patients with low serum zinc | 17 mg | 12 weeks | 27 |
| The Effect of Zinc Supplementation on Sleep Quality of ICU Nurses: A Double Blinded Randomized Controlled Trial 2018 · intervention group · ICU nurses; age and sex not specified | 73.3 mg | 30 days | 27 |
| Treatment of Wilson disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease 2006 · tetrathiomolybdate plus zinc · Primarily newly diagnosed patients with Wilson disease presenting with neurologic symptoms, not treated longer than 4 weeks with an anticopper drug | 100 mg | 8 weeks | 25 |
| Treatment of Wilson disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease 2006 · trientine plus zinc · Primarily newly diagnosed patients with Wilson disease presenting with neurologic symptoms, not treated longer than 4 weeks with an anticopper drug | 100 mg | 8 weeks | 23 |
| Evaluation of zinc sulfate mucoadhesive formulation on recurrent aphthous stomatitis: a randomized double-blind, placebo-controlled clinical trial 2020 · intervention group · Patients aged 16–45 with recurrent aphthous stomatitis | 15 mg | 7 days | 23 |
| Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial [ISRCTN64132371] 2004 · Zinc sulfate Group · Children aged 5–11 with newly diagnosed combined-subtype ADHD | 55 mg | 6 weeks | 22 |
| Zinc for attention-deficit/hyperactivity disorder: placebo-controlled double-blind pilot trial alone and combined with amphetamine 2011 · 15 mg/day qAM zinc group · Children aged 6–14 with DSM-IV ADHD | 15 mg | 13 weeks | 20 |
| Controlled trial of zinc supplementation in anorexia nervosa 1994 · zinc group · female inpatients with anorexia nervosa | 100 mg | — | 16 |
| The Effects of Zinc and Selenium Co-Supplementation on Resting Metabolic Rate, Thyroid Function, Physical Fitness, and Functional Capacity in Overweight and Obese People under a Hypocaloric Diet: A Randomized, Double-Blind, and Placebo-Controlled Trial 2023 · supplementation group · Adults aged 18–40, men and women with overweight or obesity (BMI ≥25) | 25 mg | 8 weeks | 14 |
| Normalization of zinc intake enhances neurological retrieval of patients suffering from ischemic strokes 2009 · Zn2+ group · Patients with subacute stroke and low zinc intake; age and sex not reported | 10 mg | 30 days | 13 |
| Effects of dietary zinc depletion on seminal volume and zinc loss, serum testosterone concentrations, and sperm morphology in young men 1992 · 10.4 mg Zn/d · Young men; age range and health condition not reported | 10.4 mg | 5 weeks | 11 |
| Long-term zinc and iron supplementation in children of short stature: effect of growth and on trace element content in tissues 1999 · zinc alone · Children aged 4–11 years with short stature; 16 male and 14 female participants across the study | 12.5 mg | 1 year | — |
| Zinc supplementation and stunted infants in Ethiopia: a randomised controlled trial 2000 · zinc supplement · Apparently healthy breastfed infants aged 6–12 months, including stunted and non-stunted infants | 10 mg | 26 weeks | — |
| Effect of zinc supplementation on growth and body composition in children with sickle cell disease 2002 · zinc group · Prepubertal girls and boys aged 4–10 years with sickle cell disease (SCD-SS) | 10 mg | 1 year | — |
| Effects of folic acid and zinc sulfate on male factor subfertility: a double-blind, randomized, placebo-controlled trial 2002 · zinc sulfate and placebo · Fertile and subfertile men | 66 mg | 26 weeks | — |
| C677T methylenetetrahydrofolate reductase polymorphism interferes with the effects of folic acid and zinc sulfate on sperm concentration 2003 · zinc sulfate group · fertile and subfertile males | 66 mg | 26 weeks | — |
| Zinc with oral rehydration therapy reduces stool output and duration of diarrhea in hospitalized children: a randomized controlled trial 2004 · zinc group · Male children aged 3–36 months with acute noncholera diarrhea and dehydration | 15 mg | 2 weeks | — |
| A community-based randomized controlled trial of iron and zinc supplementation in Indonesian infants: effects on growth and development 2004 · Zn group · Indonesian infants aged 6–12 months | 10 mg | 26 weeks | — |
| Zinc supplementation and psychosocial stimulation: effects on the development of undernourished Jamaican children 2005 · zinc supplementation alone · Undernourished children aged 9–30 months with weight-for-age below −1.5 z scores | 10 mg | 26 weeks | — |
| Zinc supplementation and psychosocial stimulation: effects on the development of undernourished Jamaican children 2005 · zinc supplementation plus psychosocial stimulation · Undernourished children aged 9–30 months with weight-for-age below −1.5 z scores | 10 mg | 26 weeks | — |
| Combined iron and folic acid supplementation with or without zinc reduces time to walking unassisted among Zanzibari infants 5- to 11-mo old 2006 · zinc (Zn) · Children aged 5–11 months at the start of supplementation, nutritionally at risk, in Pemba, Zanzibar | 10 mg | 1 year | — |
| Sex-specific responses to zinc supplementation in Nouna, Burkina Faso 2007 · zinc supplementation · Children aged 6–30 months in Nouna, Burkina Faso | 12.5 mg | 26 weeks | — |
| Zinc-iron, but not zinc-alone supplementation, increased linear growth of stunted infants with low haemoglobin 2007 · zinc-alone · Infants aged 3–6 months in rural East Lombok; the study included infants with stunting and low haemoglobin | 10 mg | 26 weeks | — |
| Taste acuity in response to zinc supplementation in older Europeans 2008 · 15 mg Zn/d group · Healthy adults aged 70–87 years recruited in Rome, Italy, or Grenoble, France | 15 mg | — | — |
| Zinc supplementation improved length growth only in anemic infants in a multi-country trial of iron and zinc supplementation in South-East Asia 2008 · zinc supplementation · Infants aged 4–6 months in Indonesia, Thailand, and Vietnam | 10 mg | 26 weeks | — |
| Effects of zinc supplementation on parent and teacher behaviour rating scores in low socioeconomic level Turkish primary school children 2009 · study group · Third-grade children in a low-income district primary school in Turkey | 15 mg | 10 weeks | — |
| The effects of iron and/or zinc supplementation on maternal reports of sleep in infants from Nepal and Zanzibar 2009 · zinc · Infants aged 4–18 months in Pemba Island, Zanzibar, or Sarlahi District, Nepal | 10 mg | 1 year | — |
| The effect of systemic zinc supplementation on oral health in low socioeconomic level children 2009 · study group · Healthy low socioeconomic level primary school children | 15 mg | 10 weeks | — |
| Daily supplementation with iron plus folic acid, zinc, and their combination is not associated with younger age at first walking unassisted in malnourished preschool children from a deficient population in rural Nepal 2010 · zinc · Malnourished children aged 1–36 months in a deficient population in rural Nepal | 10 mg | — | — |
| Developmental effects of micronutrient supplementation and malaria in Zanzibari children 2013 · zinc alone · Zanzibari children aged 5–14 months at baseline | 10 mg | — | — |
| Comparison of Preventive and Therapeutic Zinc Supplementation in Young Children in Burkina Faso: A Cluster-Randomized, Community-Based Trial 2016 · IPZS · Children aged 6–30 months in rural Burkina Faso | 10 mg | 48 weeks | — |
| Effects of zinc or synbiotic on the duration of diarrhea in children with acute infectious diarrhea 2016 · zinc group · Children with acute infectious diarrhea | 15 mg | 5 days | — |
| Identifying risk factors for vomiting during diarrhea: A secondary analysis of a randomized trial of zinc supplementation 2025 · 10 mg zinc group · Children aged 6–59 months with an acute episode of diarrhea | 10 mg | — | — |
| Zinc supplementation in young children with acute diarrhea in India 1995 · zinc-supplementation group · children aged 6 to 35 months with acute diarrhea in New Delhi, India | 20 mg | — | — |
| Zinc supplementation increases growth velocity of male children and adolescents with short stature 1994 · supplemented group (S) · Children and adolescents with idiopathic short stature; the arm’s age and sex breakdown is not reported | 10 mg | 1 year | — |
| Zinc supplementation increases growth and circulating insulin-like growth factor I (IGF-I) in growth-retarded Vietnamese children 1996 · zinc-treated subjects · Growth-retarded, undernourished children aged 4–36 months | 10 mg | 150 days | — |
| Zinc supplementation reduced morbidity, but neither zinc nor iron supplementation affected growth or body composition of Mexican preschoolers 1997 · zinc + iron · Mexican preschool children in a rural community | 20 mg | 1 year | — |
| Zinc supplementation affects the activity patterns of rural Guatemalan infants 1997 · Zinc-supplemented infants · Guatemalan infants recruited at 6–9 months of age | 10 mg | 30 weeks | — |
| A 14-mo zinc-supplementation trial in apparently healthy Chilean preschool children 1997 · supplemented group · Apparently healthy preschool boys and girls aged 27–50 months from low socioeconomic conditions attending daycare centers in Santiago | 10 mg | 426 days | — |
| Effects of repletion with zinc and other micronutrients on neuropsychologic performance and growth of Chinese children 1998 · ZM (zinc with micronutrients) · Children aged 6–9 years from low-income families in Chongqing, Qingdao, and Shanghai, China | 20 mg | 10 weeks | — |
| Effect of zinc supplementation on growth and body composition of Ugandan preschool children: a randomized, controlled, intervention trial 1998 · zinc supplementation · Preschool children aged 55.8 ± 11.2 months from nursery schools of medium, low, and very low socioeconomic status in a suburb of Kampala, Uganda | 10 mg | 26 weeks | — |
| Serum zinc levels in diabetic patients and effect of zinc supplementation on glycemic control of type 2 diabetics 2006 · first group (zinc-supplemented group) · Adults with type 2 diabetes; age and sex not specified | 30 mg | 90 days | 50 |
| Response to AREDS supplements according to genetic factors: survival analysis approach using the eye as the unit of analysis 2016 · combination of antioxidants and zinc · Adults aged 55 years and older with age-related macular degeneration; eyes with advanced disease at baseline and participants with no AMD in both eyes were excluded | 80 mg | 2409 days | — |
| Impact of iron fortification on anaemia and iron deficiency among pre-school children living in Rural Ghana 2021 · non-iron MNP group · Children aged 6–35 months living in rural Ghana; children with severe anaemia, severe malnutrition, recent iron supplementation, or chronic disease were excluded. | 5 mg | 150 days | 991 |
| Effect of provision of daily zinc and iron with several micronutrients on growth and morbidity among young children in Pakistan: a cluster-randomised trial 2013 · Group C: micronutrient powder with 10 mg zinc · Children enrolled at 6 months of age in Pakistan | 10 mg | 1 year | 889 |
| Vitamin A and Zinc Supplementation Among Pregnant Women to Prevent Placental Malaria: A Randomized, Double-Blind, Placebo-Controlled Trial in Tanzania 2017 · vitamin A and zinc group · Pregnant women in their first trimester, primigravid or secundigravid, HIV-negative | 25 mg | — | 625 |
| Predictors of Anaemia Among Young Children Receiving Daily Micronutrient Powders (MNPs) for 24 Weeks in Bangladesh: A Secondary Analysis of the Zinc in Powders Trial 2025 · standard MNP daily group · Children aged 9–11 months at enrolment in Bangladesh | 4.1 mg | 24 weeks | 481 |
| Enhanced effect of seasonal malaria chemoprevention when coupled with nutrients supplementation for preventing malaria in children under 5 years old in Burkina Faso: a randomized open label trial 2023 · SMC-AZc · Children aged 6–59 months living in the study area and covered by seasonal malaria chemoprevention; five children older than 59 months were included because they were covered by the campaign. | 10 mg | 90 days | 353 |
| The effect of zinc supplementation on pregnancy outcomes: a double-blind, randomised controlled trial, Egypt 2015 · combined group · Pregnant women aged 20–45 years with low serum zinc for gestational age | 30 mg | — | 227 |
| The randomized comparative pediatric critical illness stress-induced immune suppression (CRISIS) prevention trial 2012 · ZSGM · Critically ill children aged over 1 and under 18 years in the PICU with an endotracheal tube, central venous catheter, or urinary catheter | 20 mg | 4 weeks | 149 |
| Interaction Between 2 Nutraceutical Treatments and Host Immune Status in the Pediatric Critical Illness Stress-Induced Immune Suppression Comparative Effectiveness Trial 2017 · ZSGM group · Critically ill children aged over 1 and under 18 years, expected to stay in the PICU for more than 3 days with indwelling invasive devices | 20 mg | — | 127 |
| Novel Chewable Pleuran-Based Supplement Decreases Respiratory Tract Infections in Children: A Randomised Controlled Trial 2025 · active placebo group · Children aged 3–18 years with a documented history of recurrent respiratory tract infections | 5 mg | 90 days | 113 |
| Novel Chewable Pleuran-Based Supplement Decreases Respiratory Tract Infections in Children: A Randomised Controlled Trial 2025 · active group · Children aged 3–18 years with a documented history of recurrent respiratory tract infections | 5 mg | 90 days | 104 |
| Impact of vitamin A with zinc supplementation on malaria morbidity in Ghana 2013 · Vitamin A and zinc group · Children aged 6–24 months in rural Ghana | 10 mg | 26 weeks | 100 |
| [Alcohol-induced toxic hepatitis--a "free radical" associated disease. Lowering fatality by adjuvant antioxidant therapy] 1993 · antioxidant group · Patients with acute alcohol-toxic hepatitis, clinical Child/Pugh severity grades B and C; age and sex not reported | 12 mg | — | 31 |
| Simultaneous zinc and vitamin A supplementation in Bangladeshi children: randomised double blind controlled trial 2001 · zinc and vitamin A · Children aged 12–35 months living in urban slums of Dhaka, Bangladesh | 20 mg | 2 weeks | — |
| Zinc supplementation in infants born small for gestational age reduces mortality: a prospective, randomized, controlled trial 2001 · riboflavin and zinc · Full-term infants born small for gestational age, treated from 30 to 284 days of age | 5 mg | 254 days | — |
| Home-fortification with iron and zinc sprinkles or iron sprinkles alone successfully treats anemia in infants and young children 2003 · FeZn (combined supplementation group) · Anemic infants in rural Ghana; mean age 10.3 ± 2.5 months | 10 mg | 60 days | — |
| Simultaneous weekly supplementation of iron and zinc is associated with lower morbidity due to diarrhea and acute lower respiratory infection in Bangladeshi infants 2003 · 20 mg iron and 20 mg zinc with 1 mg riboflavin · Infants aged 6 months at enrollment, followed until 12 months | 2.86 mg | 183 days | — |
| Simultaneous weekly supplementation of iron and zinc is associated with lower morbidity due to diarrhea and acute lower respiratory infection in Bangladeshi infants 2003 · Micronutrient mix (MM) · Infants aged 6 months at enrollment, followed until 12 months | 2.86 mg | 183 days | — |
| Fortifying milk with ferrous gluconate and zinc oxide in a public nutrition program reduced the prevalence of anemia in toddlers 2006 · Fortified milk (FM) · Healthy, low-income children aged 10–30 months | 5.28 mg | 26 weeks | — |
| Effect of micronutrient supplementation on diarrhoeal disease among stunted children in rural South Africa 2009 · vitamin A plus zinc · children aged 6–24 months; three cohorts: HIV-infected children, HIV-uninfected children born to HIV-infected mothers, and HIV-uninfected children born to HIV-uninfected mothers | 10 mg | 548 days | — |
| The effect of probiotics and zinc supplementation on the immune response to oral rotavirus vaccine: A randomized, factorial design, placebo-controlled study among Indian infants 2018 · Probiotic supplement and zinc supplement · Infants enrolled at 35–41 days of age in India, without a medical condition precluding participation | 5 mg | 6 weeks | — |
| No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No. 18 2019 · Original AREDS formula without modification · Adults with bilateral large drusen or late AMD in one eye and large drusen in the fellow eye | 80 mg | 5 years | — |
| Impact of zinc supplementation on persistent diarrhoea in malnourished Bangladeshi children 1998 · Zinc with multivitamin · Children aged 3–24 months with persistent diarrhoea; malnourished children were the focus of the reported benefit | 20 mg | 2 weeks | — |
| Lower-Dose Zinc for Childhood Diarrhea - A Randomized, Multicenter Trial 2020 · 5 mg · Children aged 6–59 months with acute diarrhea or dysentery in India or Tanzania | 5 mg | 2 weeks | 1,504 |
| Effects of therapeutic zinc supplementation for diarrhea and two preventive zinc supplementation regimens on the incidence and duration of diarrhea and acute respiratory tract infections in rural Laotian children: A randomized controlled trial 2020 · Preventive zinc (PZ) supplementation group · Children aged 6–23 months in rural Laos | 7 mg | 40 weeks | 852 |
| Effects of Daily Zinc, Daily Multiple Micronutrient Powder, or Therapeutic Zinc Supplementation for Diarrhea Prevention on Physical Growth, Anemia, and Micronutrient Status in Rural Laotian Children: A Randomized Controlled Trial 2019 · Preventive zinc supplementation group · Children aged 6–23 months at enrollment in rural Laos; the study population included children with differing nutritional status, and enrollment was not restricted to a deficiency or diagnosis. | 7 mg | 36 weeks | 738 |
| Effects of Daily Zinc, Daily Multiple Micronutrient Powder, or Therapeutic Zinc Supplementation for Diarrhea Prevention on Physical Growth, Anemia, and Micronutrient Status in Rural Laotian Children: A Randomized Controlled Trial 2019 · Micronutrient powder group · Children aged 6–23 months at enrollment in rural Laos; the study population included children with differing nutritional status, and enrollment was not restricted to a deficiency or diagnosis. | 10 mg | 36 weeks | 701 |
| Small-quantity lipid-based nutrient supplements, regardless of their zinc content, increase growth and reduce the prevalence of stunting and wasting in young burkinabe children: a cluster-randomized trial 2015 · LNS-Zn10 · Infants aged 8.8–9.9 months at enrollment in rural Burkina Faso; no specific diagnosed condition reported | 10 mg | 39 weeks | 603 |
| Zinc and copper supplementation in acute diarrhea in children: a double-blind randomized controlled trial 2009 · zinc (Zn) only arm · Children aged 6–59 months with acute watery or bloody diarrhea | 2 mg/kg | 2 weeks | 264 |
| Double-blind, placebo-controlled study of zinc sulfate in the treatment of attention deficit hyperactivity disorder 2004 · zinc sulfate · Children with a primary DSM-IV diagnosis of ADHD; mean age 9.61 years; 72 girls and 328 boys across the trial | 150 mg | 12 weeks | 202 |
| Effect of zinc supplementation between 1 and 6 mo of life on growth and morbidity of Bangladeshi infants in urban slums 2002 · zinc group · Poor Bangladeshi infants enrolled at 4 weeks of age and followed to 24 weeks; baseline zinc-deficient and non-deficient infants | 5 mg | 20 weeks | 152 |
| Therapeutic evaluation of zinc and copper supplementation in acute diarrhea in children: double blind randomized trial 2005 · zinc and copper supplementation · Children aged 6 months to 59 months with acute diarrhea in an urban hospital | 40 mg | — | 102 |
| Zinc Supplementation in Very Low Birth Weight Infants: A Randomized Controlled Trial 2024 · control group · Preterm infants with gestational age <32 weeks and birth weight <1.5 kg | 3 mg | — | 98 |
| Zinc Supplementation in Preterm Neonates with Late-Onset Sepsis: Is It Beneficial? 2022 · group 1 (Zn and antibiotics) · Preterm neonates with late-onset sepsis | 1.4 mg/kg | 10 days | 90 |
| Zinc supplementation, mental development and behaviour in low birth weight term infants in northeast Brazil 1998 · 5 mg zinc · Term infants with low birth weight (1500–2499 g) from low-income families in Pernambuco, Brazil | 5 mg | 8 weeks | 71 |
| Effect of zinc supplementation on the morbidity, immune function, and growth of low-birth-weight, full-term infants in northeast Brazil 1998 · 5 mg Zn · Low-birth-weight, full-term infants; mean birth weight 2337 g | 5 mg | 8 weeks | 71 |
| Zinc supplementation, mental development and behaviour in low birth weight term infants in northeast Brazil 1998 · 1 mg zinc · Term infants with low birth weight (1500–2499 g) from low-income families in Pernambuco, Brazil | 1 mg | 8 weeks | 68 |
| Effect of zinc supplementation on the morbidity, immune function, and growth of low-birth-weight, full-term infants in northeast Brazil 1998 · 1 mg Zn · Low-birth-weight, full-term infants; mean birth weight 2337 g | 1 mg | 8 weeks | 68 |
| The efficacy of zinc supplementation on outcome of children with severe pneumonia. A randomized double-blind placebo-controlled clinical trial 2011 · zinc sulfate group · Children aged 3–60 months admitted to hospital with severe pneumonia | 2 mg/kg | 5 days | 64 |
| Olfactory Disturbances as Presenting Manifestation Among Egyptian Patients with COVID-19: Possible Role of Zinc 2021 · zinc therapy · Patients with COVID-19 and olfactory dysfunction (anosmia and/or hyposmia); adults, both sexes | 440 mg | — | 49 |
| Effect of zinc supplementation on growth of low birth weight infants aged 1-6 mo in Ardabil, Iran 2011 · zinc group · Low birth weight infants enrolled at birth and followed until 6 months of age | 5 mg | 26 weeks | 45 |
| Effects of zinc supplementation on physical growth in 2-5-year-old children 2009 · zinc group (ZG) · Children aged 2–5 years with height-for-age below the 25th percentile and retarded linear growth | 5 mg | 26 weeks | 40 |
| Zinc supplementation affects favorably the frequency of migraine attacks: a double-blind randomized placebo-controlled clinical trial 2020 · zinc group · Adults aged 20–60 with migraine, receiving routine migraine treatment | 220 mg | 8 weeks | 40 |
| Zinc supplementation and growth of infants born small for gestational age 1995 · supplemented group (group S) · Infants born small for gestational age, followed from birth | 3 mg | 26 weeks | 35 |
| Effect of micronutrient supplementation on the growth of preschool children in China 2002 · +Zn · Growth-retarded preschool children | 3.5 mg | 1 year | 34 |
| The Effect of Zinc Supplementation on the Improvement of Premenstrual Symptoms in Female University Students: a Randomized Clinical Trial Study 2023 · zinc group · Female university students aged 18–35 with premenstrual syndrome | 220 mg | 24 weeks | 33 |
| Zinc gluconate in the treatment of dysgeusia--a randomized clinical trial 2005 · zinc gluconate · patients with idiopathic dysgeusia; age and sex not reported | 140 mg | — | 26 |
| Evaluation of in vivo supplementation of 2660 mg D-aspartic acid and 200 mg ubiquinol and 10 mg zinc on different semen parameters in idiopathic male infertility: a randomized double blind placebo controlled study 2025 · Group (A) · Infertile men with idiopathic male infertility; age not reported | 10 mg | 90 days | 24 |
| The effect of melatonin, magnesium, and zinc on primary insomnia in long-term care facility residents in Italy: a double-blind, placebo-controlled clinical trial 2011 · supplemented group · Long-term care facility residents with primary insomnia; mean age 78.3 ± 3.9 years; sex not reported | 11.3 mg | 8 weeks | 22 |
| [Endoscopic, histologic and morphometric evaluation of the gastric mucosa in patients with osteoarthritis treated with piroxicam and zinc acexamate] 1998 · zinc acexamate group · Adults aged 30–70 with osteoarthritis and no upper digestive tract lesions at baseline | 300 mg | 4 weeks | 20 |
| Zinc supplementation increases the level of serum insulin-like growth factor-I but does not promote growth in infants with nonorganic failure to thrive 1999 · group A (zinc supplementation) · Infants aged 3–9 months with nonorganic failure to thrive | 2 mg/kg | 12 weeks | 14 |
| Evaluation of oral zinc sulfate effect on obsessive-compulsive disorder: a randomized placebo-controlled clinical trial 2012 · fluoxetine plus zinc · Patients with obsessive-compulsive disorder | 440 mg | 8 weeks | 12 |
| Effects of dietary zinc depletion on seminal volume and zinc loss, serum testosterone concentrations, and sperm morphology in young men 1992 · 1.4 mg Zn/d · Young men; age range and health condition not reported | 1.4 mg | 5 weeks | 11 |
| Effects of zinc supplementation on fatigue and quality of life in patients with colorectal cancer 2017 · Zinc Group · Adults with colorectal cancer after surgical resection, receiving chemotherapy; age range and sex not restricted | 308 mg | 16 weeks | 10 |
| Mild to moderate zinc deficiency in short children: effect of zinc supplementation on linear growth velocity 1993 · zinc-supplemented group · Prepubertal short Japanese children with mild-to-moderate zinc deficiency; boys and girls | 5 mg/kg | 26 weeks | 10 |
| Efficacy comparison between cimetidine and zinc sulphate in the treatment of multiple and recalcitrant warts 2009 · zinc sulphate group · Children and adults with multiple and recalcitrant warts | 10 mg/kg | 90 days | 9 |
| Zinc supplementation in malnourished children with persistent diarrhea in Pakistan 1999 · zinc · Hospitalized malnourished children aged 6–36 months with persistent diarrhea | 3 mg/kg | 2 weeks | — |
| Long-term zinc and iron supplementation in children of short stature: effect of growth and on trace element content in tissues 1999 · iron plus zinc · Children aged 4–11 years with short stature; 16 male and 14 female participants across the study | 12.5 mg | 1 year | — |
| Linear growth and zinc supplementation in children with short stature 2000 · zinc supplementation · Healthy pre-pubertal short children aged 7–10 years with normal GH and IGF-I levels | 5 mg/kg | 26 weeks | — |
| Effect of zinc supplementation on development and growth of Chilean infants 2001 · supplemental zinc group (SG) · healthy term infants; age range not stated | 5 mg | 1 year | — |
| Zinc supplements in breastfed infants 1992 · zinc group · Breastfed infants aged 4–9 months, mostly from low-income immigrant families and mostly of African origin | 5 mg | 90 days | — |
| Impact of zinc supplementation on diarrheal morbidity and growth pattern of low birth weight infants in kolkata, India: a randomized, double-blind, placebo-controlled, community-based study 2003 · zinc-supplemented group · Low birth weight infants from birth; sex not specified | 5 mg | 1 year | — |
| A community-based randomized controlled trial of iron and zinc supplementation in Indonesian infants: effects on growth and development 2004 · Fe+Zn group · Indonesian infants aged 6–12 months | 10 mg | 26 weeks | — |
| Iron and zinc supplementation promote motor development and exploratory behavior among Bangladeshi infants 2004 · zinc · Infants from rural Bangladesh, 6–12 months old, at risk of micronutrient deficiencies | 2.86 mg | 26 weeks | — |
| Oral zinc sulfate in the treatment of rosacea: a double-blind, placebo-controlled study 2006 · zinc sulfate · Adults aged 21–64 with rosacea | 300 mg | 13 weeks | — |
| Oral zinc sulfate in the treatment of Behcet's disease: a double blind cross-over study 2006 · Zinc sulfate phase (both crossover groups) · Patients with Behcet's disease; age and sex not specified | 300 mg | 90 days | — |
| Zinc-iron, but not zinc-alone supplementation, increased linear growth of stunted infants with low haemoglobin 2007 · zinc+iron · Infants aged 3–6 months in rural East Lombok; the study included infants with stunting and low haemoglobin | 10 mg | 26 weeks | — |
| Zinc supplementation improved length growth only in anemic infants in a multi-country trial of iron and zinc supplementation in South-East Asia 2008 · iron and zinc supplementation · Infants aged 4–6 months in Indonesia, Thailand, and Vietnam | 10 mg | 26 weeks | — |
| Zinc sulfate for relief of pruritus in patients on maintenance hemodialysis 2012 · zinc sulfate group · Adults with end-stage renal disease receiving maintenance hemodialysis | 440 mg | 60 days | — |
| Evaluation of the efficacy of zinc sulfate in the prevention of chemotherapy-induced mucositis: a double-blind randomized clinical trial 2012 · intervention group · Adult patients undergoing chemotherapy | 660 mg | — | — |
| Zinc supplementation in children and adolescents with acute leukemia 2013 · zinc supplementation · children and adolescents with acute leukemia | 2 mg/kg | 60 days | — |
| The efficacy of zinc for treatment of chronic prostatitis 2013 · study group · Patients with NIH category IIIA chronic prostatitis | 220 mg | 12 weeks | — |
| A randomized, double-blind, placebo-controlled clinical trial of the efficacy of treatment with zinc in children with intractable epilepsy 2015 · intervention group · Children aged 3–12 years with idiopathic intractable epilepsy | 1 mg/kg | 26 weeks | — |
| Comparison of Preventive and Therapeutic Zinc Supplementation in Young Children in Burkina Faso: A Cluster-Randomized, Community-Based Trial 2016 · DPZS · Children aged 6–30 months in rural Burkina Faso | 7 mg | 48 weeks | — |
| Identifying risk factors for vomiting during diarrhea: A secondary analysis of a randomized trial of zinc supplementation 2025 · 5 mg zinc group · Children aged 6–59 months with an acute episode of diarrhea | 5 mg | — | — |
| The Effectiveness of Zinc-Biofortified Wheat Flour Intake on the Growth and Morbidity Outcomes of Rural Pakistani Children and Adolescent Girls: A Cluster-Randomised, Double-Blind, Controlled Trial 2025 · Biofortified flour (Zincol-2016) · Adolescent girls aged 10–16 years and children aged 1–5 years in rural Pakistan; the biofortified flour was provided to participating households | 1.5 mg | 25 weeks | — |
| A randomized, controlled clinical trial to evaluate the effects of zinc sulfate on cancer patients with taste alterations caused by head and neck irradiation 1998 · zinc sulfate · Cancer patients receiving external radiotherapy to the head and neck who developed taste alterations | 135 mg | — | — |
| Treatment of asthenozoospermia with zinc sulphate: andrological, immunological and obstetric outcome 1998 · zinc therapy group · men with asthenozoospermia | 500 mg | 90 days | — |
| Zinc and rehabilitation from severe protein-energy malnutrition: higher-dose regimens are associated with increased mortality 1998 · 1.5 mg/kg for 15 d · Children aged 6 months to 3 years with severe protein-energy malnutrition admitted to a nutritional rehabilitation unit | 1.5 mg/kg | 15 days | — |
| Zinc and rehabilitation from severe protein-energy malnutrition: higher-dose regimens are associated with increased mortality 1998 · 6.0 mg/kg for 15 d · Children aged 6 months to 3 years with severe protein-energy malnutrition admitted to a nutritional rehabilitation unit | 6 mg/kg | 15 days | — |
| Zinc and rehabilitation from severe protein-energy malnutrition: higher-dose regimens are associated with increased mortality 1998 · 6.0 mg/kg for 30 d · Children aged 6 months to 3 years with severe protein-energy malnutrition admitted to a nutritional rehabilitation unit | 6 mg/kg | 30 days | — |
| The impact of vitamins and/or mineral supplementation on blood pressure in type 2 diabetes 2004 · group M · People with type 2 diabetes; age and sex not reported | 30 mg | 90 days | 16 |
| Impact of iron fortification on anaemia and iron deficiency among pre-school children living in Rural Ghana 2021 · iron-MNP group · Children aged 6–35 months living in rural Ghana; children with severe anaemia, severe malnutrition, recent iron supplementation, or chronic disease were excluded. | 5 mg | 150 days | 967 |
| Effects of fortified milk on morbidity in young children in north India: community based, randomised, double masked placebo controlled trial 2007 · fortified milk · Children aged 1–3 years in a peri-urban settlement in north India | 7.8 mg | 1 year | 316 |
| Antioxidant supplement and long-term reduction of recurrent adenomas of the large bowel. A double-blind randomized trial 2013 · active compound · Patients who had undergone polypectomy and were undergoing post-polypectomy endoscopic follow-up | 30 mg | 5 years | 164 |
| Cow's milk-based beverage consumption in 1- to 4-year-olds and allergic manifestations: an RCT 2016 · CMBB · Children aged 1 to 4 years attending daycare in Brazil; generally healthy, without a stated diagnosed condition | 6.9 mg | 28 weeks | 125 |
| Effect of an Immune-Boosting, Antioxidant and Anti-Inflammatory Food Supplement in Hospitalized COVID-19 Patients: A Prospective Randomized Pilot Study 2023 · intervention group · Adults aged 18 years or older hospitalized with PCR-confirmed COVID-19 who required more than 48 hours of admission | 1.5 mg | — | 78 |
| Difensil Immuno Reduces Recurrence and Severity of Tonsillitis in Children: A Randomized Controlled Trial 2020 · Group B (GB) · Children younger than 8 years with at least 3 fever-associated tonsillitis episodes per year and Mackenzie score >2 | 11.2 mg | 45 days | 41 |
| Difensil Immuno Reduces Recurrence and Severity of Tonsillitis in Children: A Randomized Controlled Trial 2020 · Group A (GA) · Children younger than 8 years with at least 3 fever-associated tonsillitis episodes per year and Mackenzie score >2 | 7.5 mg | 90 days | 40 |
| Effects of perioperative vitamin E and zinc co-supplementation on systemic inflammation and length of stay following coronary artery bypass graft surgery: a randomized controlled trial 2024 · intervention group · Patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass; age and sex not reported | 30 mg | 3 weeks | 40 |
| Megadose vitamins in bladder cancer: a double-blind clinical trial 1994 · megadose vitamins arm · Patients with biopsy-confirmed transitional cell carcinoma of the bladder receiving BCG immunotherapy | 90 mg | — | 35 |
| "The SU.VI.MAX Study": a primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers. SUpplementation on VItamines et Minéraux AntioXydants 1999 · antioxidant vitamins and minerals supplementation · Women aged 35 to 60 years and men aged 45 to 60 years, without a stated condition | 20 mg | 8 years | — |
| A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8 2001 · Antioxidants plus zinc · Adults aged 55–80 with age-related macular degeneration Categories 2–4 and visual acuity of 20/32 or better in at least one eye | 80 mg | 8 years | — |
| Zinc supplementation in infants born small for gestational age reduces mortality: a prospective, randomized, controlled trial 2001 · riboflavin, zinc, calcium, phosphorus, folate, and iron · Full-term infants born small for gestational age, treated from 30 to 284 days of age | 5 mg | 254 days | — |
| Effects of multimicronutrient supplementation on helminth reinfection: a randomized, controlled trial in Kenyan schoolchildren 2003 · multimicronutrient supplementation · Schoolchildren in Nyanza Province, Kenya; age and sex not specified | 20 mg | 335 days | — |
| Effects of maternal micronutrient supplementation on fetal loss and infant mortality: a cluster-randomized trial in Nepal 2003 · Folic acid + iron + zinc · Pregnant women in rural Nepal | 30 mg | — | — |
| Effects of maternal micronutrient supplementation on fetal loss and infant mortality: a cluster-randomized trial in Nepal 2003 · Multiple micronutrients · Pregnant women in rural Nepal | 30 mg | — | — |
| Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13 2004 · antioxidants plus zinc · Adults aged 55–81 years with AMD categories 2–4 and AREDS ocular eligibility | 80 mg | 339 weeks | — |
| The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals 2004 · antioxidant supplement group · French women aged 35–60 and men aged 45–60 in the general population | 20 mg | 2739 days | — |
| Trial of zinc supplements in relation to pregnancy outcomes, hematologic indicators, and T cell counts among HIV-1-infected women in Tanzania 2005 · Zinc group · Pregnant women with HIV-1 infection, recruited at 12–27 weeks of gestation | 25 mg | — | — |
| Antioxidant status and risk of cancer in the SU.VI.MAX study: is the effect of supplementation dependent on baseline levels? 2005 · daily antioxidant supplementation · French adults: women aged 35–60 years and men aged 45–60 years | 20 mg | 2739 days | — |
| [The SU.VI.MAX study, a randomized, placebo-controlled trial on the effects of antioxidant vitamins and minerals on health] 2006 · antioxidant supplementation · Middle-aged adults in the general population | 20 mg | 2738 days | — |
| Antioxidant supplementation increases the risk of skin cancers in women but not in men 2007 · antioxidant group · French adult women and men in a general-population primary-prevention trial | 20 mg | 2738 days | — |
| Effect of micronutrient supplementation on diarrhoeal disease among stunted children in rural South Africa 2009 · multiple micronutrients · children aged 6–24 months; three cohorts: HIV-infected children, HIV-uninfected children born to HIV-infected mothers, and HIV-uninfected children born to HIV-uninfected mothers | 10 mg | 548 days | — |
| Incidence of cancers, ischemic cardiovascular diseases and mortality during 5-year follow-up after stopping antioxidant vitamins and minerals supplements: a postintervention follow-up in the SU.VI.MAX Study 2010 · antioxidant supplementation · French women aged 35–60 years and men aged 45–60 years | 20 mg | 2738 days | — |
| Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35 2013 · Antioxidants plus zinc · Adults aged 55–80 with age-related macular degeneration (AREDS categories 1–4) | 80 mg | 339 weeks | — |
| No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38 2014 · antioxidants plus zinc · Adults with intermediate age-related macular degeneration in one or both eyes or late age-related macular degeneration in one eye; mean age 69 years | 80 mg | 9 years | — |
| Effect of micronutrient supplementation on infection in institutionalized elderly subjects: a controlled trial 1997 · combination of trace elements and vitamins · Institutionalized elderly subjects in a geriatric center; low serum vitamin C, zinc and selenium were common at baseline | 20 mg | 2 years | — |
| Effects of therapeutic zinc supplementation for diarrhea and two preventive zinc supplementation regimens on the incidence and duration of diarrhea and acute respiratory tract infections in rural Laotian children: A randomized controlled trial 2020 · MNP group · Children aged 6–23 months in rural Laos | 10 mg | 40 weeks | 852 |
| Effect of preventive supplementation with zinc and other micronutrients on non-malarial morbidity in Tanzanian pre-school children: a randomized trial 2012 · Multi-nutrients with zinc · Children aged 6–60 months with height-for-age z-score ≤−1.5 SD, in rural Tanzania | 10 mg | — | 151 |
| Effects of vitamin C, vitamin E, zinc gluconate, and selenomethionine supplementation on muscle function and oxidative stress biomarkers in patients with facioscapulohumeral dystrophy: a double-blind randomized controlled clinical trial 2015 · supplemented group · Adults with facioscapulohumeral muscular dystrophy (FSHD) | 25 mg | 17 weeks | 26 |
| Improving neuropathy scores in type 2 diabetic patients using micronutrients supplementation 2011 · Group MV · Patients with type 2 diabetes | 20 mg | 120 days | — |
| Small-quantity lipid-based nutrient supplements, regardless of their zinc content, increase growth and reduce the prevalence of stunting and wasting in young burkinabe children: a cluster-randomized trial 2015 · LNS-TabZn5 · Infants aged 8.8–9.9 months at enrollment in rural Burkina Faso; no specific diagnosed condition reported | 5 mg | 39 weeks | 617 |
| Small-quantity lipid-based nutrient supplements, regardless of their zinc content, increase growth and reduce the prevalence of stunting and wasting in young burkinabe children: a cluster-randomized trial 2015 · LNS-Zn5 · Infants aged 8.8–9.9 months at enrollment in rural Burkina Faso; no specific diagnosed condition reported | 5 mg | 39 weeks | 613 |
| Efficacy of zinc supplementation in reducing the incidence and prevalence of acute diarrhea--a community-based, double-blind, controlled trial 1997 · zinc group · Children aged 6–35 months in a low-socioeconomic-status urban Indian community | 10 mg | 26 weeks | 286 |
| Maternal zinc supplementation and growth in Peruvian infants 2008 · zinc group · Pregnant women enrolled at 10–24 weeks of gestation; low-risk pregnancy | 15 mg | — | 273 |
| Zinc and copper supplementation in acute diarrhea in children: a double-blind randomized controlled trial 2009 · zinc and copper (Zn+Cu) arm · Children aged 6–59 months with acute watery or bloody diarrhea | 2 mg/kg | 2 weeks | 273 |
| Effectiveness of zinc supplementation to full term normal infants: a community based double blind, randomized, controlled, clinical trial 2013 · Zinc · Full-term, healthy infants from a low-income urban community in India, supplemented from 4 to 18 months of age | 5 mg | 360 days | 163 |
| Effect on longitudinal growth and anemia of zinc or multiple micronutrients added to vitamin A: a randomized controlled trial in children aged 6-24 months 2010 · Vitamin A + zinc · Children enrolled at 6 months and followed to 24 months in rural South Africa; HIV-infected and HIV-uninfected children, both sexes | 10 mg | 548 days | 123 |
| Comparison of the Efficacy of Polaprezinc Plus Proton Pump Inhibitor and Rebamipide Plus Proton Pump Inhibitor Treatments for Endoscopic Submucosal Dissection-induced Ulcers 2021 · PPI plus polaprezinc group · Adults aged 20–80 with gastric adenoma or cancer undergoing endoscopic submucosal dissection | 150 mg | 4 weeks | 104 |
| Randomized controlled trial of the effect of daily supplementation with zinc or multiple micronutrients on the morbidity, growth, and micronutrient status of young Peruvian children 2004 · Zn+VM · Children aged 6–35 months with persistent diarrhea, supplemented after the diarrhea episode ended | 10 mg | 26 weeks | 82 |
| Impact of zinc supplementation on subsequent morbidity and growth in Bangladeshi children with persistent diarrhoea 2007 · Zinc group · Children aged 3–24 months, both sexes, hospitalized with persistent diarrhoea; included malnourished children | 20 mg | 2 weeks | 78 |
| Major reduction of malaria morbidity with combined vitamin A and zinc supplementation in young children in Burkina Faso: a randomized double blind trial 2008 · supplemented group · Children aged 6–72 months in a malaria-endemic area of Burkina Faso | 10 mg | 26 weeks | 74 |
| Effect of oral zinc supplementation on the growth of preterm infants 2010 · Group I · Preterm infants weighing 1000 to 2500 g | 2 mg/kg | 6 weeks | 50 |
| Effect of micronutrient supplementation on the growth of preschool children in China 2002 · +ZnCa · Growth-retarded preschool children | 3.5 mg | 1 year | 37 |
| Evaluation of a diet containing probiotics and zinc for the treatment of mild diarrheal illness in children younger than one year of age 2005 · supplemented group · Children aged 6–12 months with acute gastroenteritis | 10 mg | — | 33 |
| Daily consumption of ready-to-use peanut-based therapeutic food increased fat free mass, improved anemic status but has no impact on the zinc status of people living with HIV/AIDS: a randomized controlled trial 2016 · RUTF group · Adult men and women with HIV/AIDS hospitalized in Senegal, with malnutrition common in the study population | 7 mg | 90 days | 32 |
| Effect of micronutrient supplementation on the growth of preschool children in China 2002 · +ZnCaVA · Growth-retarded preschool children | 3.5 mg | 1 year | 28 |
| A randomized controlled clinical trial of zinc, vitamin A or both in undernourished children with persistent diarrhea in Bangladesh 2001 · zinc · Bangladeshi children aged 6 months to 2 years with persistent diarrhea and moderate malnutrition | 40 mg | 7 days | 24 |
| A randomized controlled clinical trial of zinc, vitamin A or both in undernourished children with persistent diarrhea in Bangladesh 2001 · zinc plus vitamin A · Bangladeshi children aged 6 months to 2 years with persistent diarrhea and moderate malnutrition | 40 mg | 7 days | 24 |
| Efficacy of spirulina extract plus zinc in patients of chronic arsenic poisoning: a randomized placebo-controlled study 2006 · spirulina extract plus zinc · Patients with chronic arsenic poisoning | 4 mg | 16 weeks | 24 |
| Mirazid alone or combined with Paromomycin in treating cryptosporidiosis parvum in immunocompetent hospitalized patients 2008 · G2 · Children from a few months to 10 years old with cryptosporidiosis; sex not specified by arm | 20 mg | 2 weeks | 20 |
| Effect of zinc supplementation on mood states in young women: a pilot study 2010 · MV and Zn group · Young women; age range and health status not specified | 7 mg | 10 weeks | 15 |
| Double-blind, randomized, controlled trial of zinc or vitamin A supplementation in young children with acute diarrhoea 1999 · zinc, 14.2 mg elemental zinc dose · Children aged 6 months to 2 years with acute watery diarrhoea of 3 days or less and some dehydration; this dose was used for the first 417 patients assigned to the zinc group | 14.2 mg | 15 days | — |
| Double-blind, randomized, controlled trial of zinc or vitamin A supplementation in young children with acute diarrhoea 1999 · zinc, 40 mg dose · Children aged 6 months to 2 years with acute watery diarrhoea of 3 days or less and some dehydration; this dose was used for the remaining 273 patients assigned to the zinc group | 40 mg | 15 days | — |
| Vitamin A and zinc supplementation of preschool children 1999 · Zn and vitamin A · Children aged 22 to 66 months in Belize, selected for low or marginal serum micronutrient concentrations | 10 mg | 26 weeks | — |
| Impact of zinc supplementation on subsequent growth and morbidity in Bangladeshi children with acute diarrhoea 1999 · Elemental zinc in multivitamin syrup · Children aged 3–24 months with malnutrition and acute diarrhoea | 20 mg | 2 weeks | — |
| Zinc supplementation might potentiate the effect of vitamin A in restoring night vision in pregnant Nepalese women 2001 · beta-carotene + zinc · Pregnant women who developed night blindness; age not reported | 25 mg | 3 weeks | — |
| Zinc supplementation might potentiate the effect of vitamin A in restoring night vision in pregnant Nepalese women 2001 · vitamin A + zinc · Pregnant women who developed night blindness; age not reported | 25 mg | 3 weeks | — |
| Effects of folic acid and zinc sulfate on male factor subfertility: a double-blind, randomized, placebo-controlled trial 2002 · zinc sulfate and folic acid · Fertile and subfertile men | 66 mg | 26 weeks | — |
| C677T methylenetetrahydrofolate reductase polymorphism interferes with the effects of folic acid and zinc sulfate on sperm concentration 2003 · folic acid and zinc sulfate group · fertile and subfertile males | 66 mg | 26 weeks | — |
| Randomized, double-blind, placebo-controlled clinical trial of the efficacy of treatment with zinc or vitamin A in infants and young children with severe acute lower respiratory infection 2004 · zinc plus vitamin A · Children aged 2–24 months hospitalized with severe acute lower respiratory infection | 20 mg | 5 days | — |
| Iron and zinc supplementation promote motor development and exploratory behavior among Bangladeshi infants 2004 · iron+zinc · Infants from rural Bangladesh, 6–12 months old, at risk of micronutrient deficiencies | 2.86 mg | 26 weeks | — |
| Effect of vitamin A and zinc supplementation on the nutriture of children in Northeast Thailand 1992 · zinc plus vitamin A · Children aged 6–13 years with marginal plasma retinol and zinc concentrations | 25 mg | 26 weeks | — |
| Does folic acid and zinc sulphate intervention affect endocrine parameters and sperm characteristics in men? 2006 · Folic acid and zinc sulphate intervention · Fertile and subfertile males | 66 mg | 26 weeks | — |
| Combined iron and folic acid supplementation with or without zinc reduces time to walking unassisted among Zanzibari infants 5- to 11-mo old 2006 · iron+folic acid+zinc (FeFA+Zn) · Children aged 5–11 months at the start of supplementation, nutritionally at risk, in Pemba, Zanzibar | 10 mg | 1 year | — |
| Zinc-iron, but not zinc-alone supplementation, increased linear growth of stunted infants with low haemoglobin 2007 · zinc+iron+vitamin-A · Infants aged 3–6 months in rural East Lombok; the study included infants with stunting and low haemoglobin | 10 mg | 26 weeks | — |
| Zinc supplementation in the management of shigellosis in malnourished children in Bangladesh 2008 · Zinc (intervention) · Moderately malnourished children aged 12–59 months with culture-proven shigellosis | 20 mg | 2 weeks | — |
| The effects of iron and/or zinc supplementation on maternal reports of sleep in infants from Nepal and Zanzibar 2009 · iron–folic acid and zinc · Infants aged 4–18 months in Pemba Island, Zanzibar, or Sarlahi District, Nepal | 10 mg | 1 year | — |
| Interaction of zinc or vitamin A supplementation and specific parasite infections on Mexican infants' growth: a randomized clinical trial 2009 · combined vitamin A-zinc supplement · Children aged 5–15 months | 20 mg | 1 year | — |
| Zinc supplementation for four months does not affect growth in young north Indian children 2010 · Zinc group: infants aged 6–11 months · Children aged 6–11 months in New Delhi, India | 10 mg | 120 days | — |
| Zinc supplementation for four months does not affect growth in young north Indian children 2010 · Zinc group: children aged 12–30 months · Children aged 12–30 months in New Delhi, India | 20 mg | 120 days | — |
| Maternal zinc supplementation reduces diarrheal morbidity in peruvian infants 2010 · zinc · Pregnant women in a periurban slum of Lima, Peru | 15 mg | — | — |
| Daily supplementation with iron plus folic acid, zinc, and their combination is not associated with younger age at first walking unassisted in malnourished preschool children from a deficient population in rural Nepal 2010 · zinc+iron+folic acid · Malnourished children aged 1–36 months in a deficient population in rural Nepal | 10 mg | — | — |
| Zinc combined with vitamin A reduces upper respiratory tract infection morbidity in a randomised trial in preschool children in Indonesia 2012 · Zinc group; all children received vitamin A · Children aged 2–5 years in Indonesia | 10 mg | 120 days | — |
| Developmental effects of micronutrient supplementation and malaria in Zanzibari children 2013 · FeFA with zinc · Zanzibari children aged 5–14 months at baseline | 10 mg | — | — |
| Zinc supplementation sustained normative neurodevelopment in a randomized, controlled trial of Peruvian infants aged 6-18 months 2014 · zinc, iron, and copper supplement · Infants aged 6–18 months | 10 mg | 1 year | — |
| Comparison of methods to assess adherence to small-quantity lipid-based nutrient supplements (SQ-LNS) and dispersible tablets among young Burkinabé children participating in a community-based intervention trial 2015 · SQ-LNS and 5 mg zinc dispersible tablet · Children aged 9–18 months in Burkina Faso | 5 mg | 270 days | — |
| Effects of zinc, vitamin D, and their co-supplementation on mood, serum cortisol, and brain-derived neurotrophic factor in patients with obesity and mild to moderate depressive symptoms: A phase II, 12-wk, 2 × 2 factorial design, double-blind, randomized, placebo-controlled trial 2020 · Vitamin D plus zinc group · Overweight or obese adults with depressive symptoms and BDI-II score ≥10; mean age 38.35 years | 30 mg | 12 weeks | — |
| Randomised controlled trial of zinc supplementation in malnourished Bangladeshi children with acute diarrhoea 1997 · Zinc-containing multivitamins · Children aged 3 to 24 months with acute diarrhoea and malnutrition (below 76% median weight for age) | 20 mg | 2 weeks | — |
| Adding zinc to prenatal iron and folate tablets improves fetal neurobehavioral development 1999 · iron, folate, and zinc · Pregnant women in a Peruvian population; gestational age not otherwise specified | 15 mg | — | — |
| Reported zinc, but not copper, intakes influence whole-body bone density, mineral content and T score responses to zinc and copper supplementation in healthy postmenopausal women 2011 · 600 mg Ca plus 2 mg Cu and 12 mg Zn · Healthy postmenopausal women aged 51–80 years | 12 mg | 2 years | 112 |
| Spinal bone loss in postmenopausal women supplemented with calcium and trace minerals 1994 · trace minerals only · Healthy postmenopausal women, mean age 66 years | 15 mg | 2 years | — |
| Effect of zinc supplementation in children with asthma: a randomized, placebo-controlled trial in northern Islamic Republic of Iran 2014 · zinc supplements · Children with asthma attending an outpatient clinic; ages and sex not specified; participants had low initial serum zinc concentrations. | 50 mg | 8 weeks | 144 |
| Zinc taste test in pregnant women and its correlation with serum zinc level 1993 · study group · pregnant women in different trimesters of pregnancy | 45 mg | — | 104 |
| Plasma and Nail Zinc Concentrations, But Not Hair Zinc, Respond Positively to Two Different Forms of Preventive Zinc Supplementation in Young Laotian Children: a Randomized Controlled Trial 2021 · TZ group (therapeutic zinc tablets for diarrhea) · Children aged 6–23 months in Lao PDR who received treatment during diarrhea episodes | 20 mg | 10 days | 83 |
| Zinc influences innate immune responses in children with enterotoxigenic Escherichia coli-induced diarrhea 2010 · zinc treatment (ZT) · Children aged 6–24 months with ETEC-induced diarrhea | 20 mg | 10 days | 74 |
| Comparison of zinc acetate hydrate and polaprezinc for zinc deficiency in patients on maintenance hemodialysis: A single-center, open-label, prospective randomized study 2020 · PPZ group · Patients on maintenance hemodialysis with serum zinc level <70 μg/dL | 34 mg | — | 47 |
| Comparison of zinc acetate hydrate and polaprezinc for zinc deficiency in patients on maintenance hemodialysis: A single-center, open-label, prospective randomized study 2020 · ZAH group · Patients on maintenance hemodialysis with serum zinc level <70 μg/dL | 50 mg | — | 44 |
| Antioxidant effect of zinc supplementation on both plasma and cellular red-ox status markers in a group of elderly Italian population 2014 · 30 mg Zn group · Healthy Italian adults aged 70–85 years; men and women | 30 mg | 26 weeks | 35 |
| Effects of Zinc Acetate on Serum Zinc Concentrations in Chronic Liver Diseases: a Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial and a Dose Adjustment Trial 2020 · NPC-02 group (Study 1) · Adults aged 20 years or older with chronic liver disease and hypozincemia (serum zinc <70 μg/dL) | 50 mg | 8 weeks | 31 |
| Effectiveness of eight-week zinc supplementation on vitamin D(3) status and leptin levels in a population of postmenopausal women: a double-blind randomized trial 2021 · zinc group · Healthy postmenopausal women aged 44–76 years | 50 mg | 8 weeks | 26 |
| Brief Report: Zinc Supplementation and Inflammation in Treated HIV 2019 · low-dose arm · Adults aged 18 years or older with HIV-1 on stable antiretroviral therapy and documented zinc deficiency | 45 mg | 16 weeks | 25 |
| Oral zinc supplementation in persistent diarrhoea in infants 1990 · group A · Infants aged 6–18 months with persistent diarrhoea lasting more than 2 weeks | 40 mg | — | 20 |
| Effect of zinc supplementation on inflammatory markers and adipokines in young obese women 2014 · zinc supplementation group · Obese women aged 19–28 years | 30 mg | 8 weeks | 20 |
| Maternal zinc supplementation improves hepatitis B antibody responses in infants but decreases plasma zinc level 2016 · zinc group · Mothers starting supplementation at the beginning of the second trimester and continuing through 6 months postpartum; infants’ immune outcomes were assessed | 20 mg | — | 20 |
| Short-term zinc supplementation in women with non-insulin-dependent diabetes mellitus: effects on plasma 5'-nucleotidase activities, insulin-like growth factor I concentrations, and lipoprotein oxidation rates in vitro 1997 · zinc supplementation · Postmenopausal women with non-insulin-dependent diabetes mellitus | 30 mg | 3 weeks | 20 |
| Zinc-Biofortified Wheat Intake and Zinc Status Biomarkers in Men: Randomized Controlled Trial 2021 · 25-mg zinc supplement group · Healthy adult men aged 18–51 years | 25 mg | 2 weeks | 18 |
| Zinc Supplements Taken with Food Increase Essential Fatty Acid Desaturation Indices in Adult Men Compared with Zinc Taken in the Fasted State 2021 · zinc before breakfast (ZBB) · Apparently healthy adult men | 25 mg | 13 days | 18 |
| Lipid peroxidation in insulin-dependent diabetic patients with early retina degenerative lesions: effects of an oral zinc supplementation 1995 · zinc gluconate · Adults with type 1 diabetes mellitus, including patients with early retinopathy and patients without retinopathy | 30 mg | 90 days | 18 |
| Zinc Supplements Taken with Food Increase Essential Fatty Acid Desaturation Indices in Adult Men Compared with Zinc Taken in the Fasted State 2021 · zinc with breakfast (ZWB) · Apparently healthy adult men | 25 mg | 13 days | 17 |
| Long-term moderate zinc supplementation increases exchangeable zinc pool masses in late-middle-aged men: the Zenith Study 2005 · 30 mg Zn group · Healthy, late-middle-aged men | 30 mg | 26 weeks | 16 |
| Effect of zinc supplementation on serum zinc concentration and T cell proliferation in nursing home elderly: a randomized, double-blind, placebo-controlled trial 2016 · zinc group · Nursing-home residents aged 65 years or older with low serum zinc concentrations | 30 mg | 90 days | 16 |
| Low dietary zinc decreases erythrocyte carbonic anhydrase activities and impairs cardiorespiratory function in men during exercise 2005 · supplemented diet · Men aged 20–31 years | 18.7 mg | 9 weeks | 14 |
| The pharmacokinetics of zinc from zinc gluconate: a comparison with zinc oxide in healthy men 2005 · zinc gluconate · healthy men aged 21–31 years | 20 mg | 2 weeks | 12 |
| Supplemental zinc lowers measures of iron status in young women with low iron reserves 2002 · zinc-supplemented group · Women aged 20–28 years who were nonanemic and had low iron stores (plasma ferritin <20 microg/L) | 22 mg | 6 weeks | 11 |
| Antioxidant effect of zinc in humans 2004 · zinc supplementation · healthy normal adult volunteers; age and sex not specified | 45 mg | 8 weeks | 10 |
| Effect of intragastric pH on the absorption of oral zinc acetate and zinc oxide in young healthy volunteers 1995 · zinc acetate, low intragastric pH (AL) · young healthy adults, 5 men and 5 women | 50 mg | 1 day | 10 |
| Effect of intragastric pH on the absorption of oral zinc acetate and zinc oxide in young healthy volunteers 1995 · zinc acetate, high intragastric pH (AH) · young healthy adults, 5 men and 5 women | 50 mg | 1 day | 10 |
| Effect of intragastric pH on the absorption of oral zinc acetate and zinc oxide in young healthy volunteers 1995 · zinc oxide, low intragastric pH (OL) · young healthy adults, 5 men and 5 women | 50 mg | 1 day | 10 |
| Effect of intragastric pH on the absorption of oral zinc acetate and zinc oxide in young healthy volunteers 1995 · zinc oxide, high intragastric pH (OH) · young healthy adults, 5 men and 5 women | 50 mg | 1 day | 10 |
| Plasma zinc, copper, and serum thyroid hormones and insulin levels after zinc supplementation followed by placebo in competitive athletes 2011 · zinc supplementation · Competitive cyclists, 32 ± 8 years; sex and health condition not specified | 22 mg | 30 days | 7 |
| Iron and zinc supplementation improves indicators of vitamin A status of Mexican preschoolers 2000 · zinc · Rural Mexican children aged 18–36 months | 20 mg | 26 weeks | — |
| Synergistic effect of zinc and vitamin A on the biochemical indexes of vitamin A nutrition in children 2002 · Z group · Children aged 12–35 months; vitamin A-deficient children were a reported subgroup | 20 mg | 2 weeks | — |
| Effect of vitamin C and zinc on osmotic fragility and lipid peroxidation in zinc-deficient haemodialysis patients 2002 · zinc · Zinc-deficient haemodialysis patients | 20 mg | 90 days | — |
| The effects of zinc supplementation on serum zinc and cholesterol concentrations in hemodialysis patients 2002 · zinc-supplemented group · Maintenance hemodialysis patients; 20 participants completed the study, with serum zinc below the normal range at baseline. | 50 mg | 90 days | — |
| Zinc supplementation has no effect on lipoprotein metabolism, hemostasis, and putative indices of copper status in healthy men 2003 · Group 1 — zinc supplementation · Healthy men; age range not reported | 30 mg | 14 weeks | — |
| Age- and sex-dependent effects of long-term zinc supplementation on essential trace element status and lipid metabolism in European subjects: the Zenith Study 2007 · 30 mg zinc group · Healthy adults aged 55–70 or 70–85 years | 30 mg | 26 weeks | — |
| Effect of zinc supplementation on vitamin status of middle-aged and older European adults: the ZENITH study 2008 · 30 mg Zn/day group · Healthy men and women aged 55–70 or 70–85 years | 30 mg | 26 weeks | — |
| Effect of zinc and iron supplementation on indicators of iron, zinc and vitamin A status of primary school children 2007 · zinc · 11-year-old primary school children | 20 mg | 120 days | — |
| Zinc decreases C-reactive protein, lipid peroxidation, and inflammatory cytokines in elderly subjects: a potential implication of zinc as an atheroprotective agent 2010 · zinc group · healthy elderly subjects aged 56–83 years | 45 mg | 26 weeks | — |
| Plasma zinc concentration responds rapidly to the initiation and discontinuation of short-term zinc supplementation in healthy men 2010 · 20 mg Zn/d · Healthy males aged 19–54 years | 20 mg | 3 weeks | — |
| Oral zinc sulphate supplementation for six months in SCA2 patients: a randomized, double-blind, placebo-controlled trial 2011 · Zinc-treated group · Cuban patients with Spinocerebellar Ataxia type 2 (SCA2) | 50 mg | 26 weeks | — |
| Pre-dialysis serum creatinine as an independent predictor of responsiveness to zinc supplementation among patients on hemodialysis 2020 · zinc acetate hydrate (ZAH) · Patients on maintenance hemodialysis; age and sex not specified | 50 mg | 90 days | — |
| Pre-dialysis serum creatinine as an independent predictor of responsiveness to zinc supplementation among patients on hemodialysis 2020 · polaprezinc (PPZ) · Patients on maintenance hemodialysis; age and sex not specified | 34 mg | 90 days | — |
| Urinary zinc as a marker of zinc intake: results of a supplementation trial in free-living men 1994 · 50 mg zinc · Adult male volunteers; age range and health status not specified | 50 mg | 7 days | — |
| Plasma and erythrocyte zinc concentrations and their relationship to dietary zinc intake and zinc supplementation during pregnancy in low-income African-American women 1997 · zinc group · Low-income African-American women assigned at 19 weeks of gestation | 25 mg | — | — |
| Micronutrient fortified milk improves iron status, anemia and growth among children 1-4 years: a double masked, randomized, controlled trial 2010 · Micronutrient-fortified milk (MN group) · Children aged 1–4 years in India; many had anemia, iron deficiency, or growth faltering | 7.8 mg | 1 year | 316 |
| Effect on longitudinal growth and anemia of zinc or multiple micronutrients added to vitamin A: a randomized controlled trial in children aged 6-24 months 2010 · Multiple micronutrients · Children enrolled at 6 months and followed to 24 months in rural South Africa; HIV-infected and HIV-uninfected children, both sexes | 10 mg | 548 days | 126 |
| Melatonin, vitamins and minerals supplements for the treatment of Covid-19 and Covid-like illness: A prospective, randomized, double-blind multicenter study 2024 · Treatment group · Adults younger than 60 years with COVID-19 or COVID-like illness, no previous medical history, and not hospitalized | 25 mg | — | 82 |
| Effect of zinc plus multivitamin supplementation on growth in school children 2016 · Chelated zinc plus multivitamins · Healthy Thai schoolchildren aged 4–13 years | 20 mg | 26 weeks | 70 |
| Effect of zinc supplementation on observed activity in low socioeconomic Indian preschool children 1996 · zinc group · Children aged 12–23 months from a low-socioeconomic urban population in New Delhi | 10 mg | — | 48 |
| Effects of Low-Dose Dairy Protein Plus Micronutrient Supplementation during Resistance Exercise on Muscle Mass and Physical Performance in Older Adults: A Randomized, Controlled Trial 2018 · ExPM (resistance exercise plus low-dose dairy protein and micronutrient supplementation) · Adults aged 65–80 years, non-disabled and not exercising regularly | 8 mg | 12 weeks | 40 |
| TOZAL Study: an open case control study of an oral antioxidant and omega-3 supplement for dry AMD 2007 · Sham MCS and nutritional supplement · Adults aged 50–90 with dry age-related macular degeneration in at least one eye | 69.6 mg | 24 weeks | 37 |
| A Collagen Supplement Improves Skin Hydration, Elasticity, Roughness, and Density: Results of a Randomized, Placebo-Controlled, Blind Study 2019 · verum group · Women aged 35–73 with healthy skin | 3 mg | 12 weeks | 36 |
| Efficacy and Safety of the Combination of Palmitoylethanolamide, Superoxide Dismutase, Alpha Lipoic Acid, Vitamins B12, B1, B6, E, Mg, Zn and Nicotinamide for 6 Months in People with Diabetic Neuropathy 2024 · 10-element combination tablet · Overweight or obese adults with type 2 diabetes and mild-to-moderate painful diabetic neuropathy; mean age 63 years | 5 mg | 26 weeks | 36 |
| Effect of a mixture of micronutrients, but not of bovine colostrum concentrate, on immune function parameters in healthy volunteers: a randomized placebo-controlled study 2006 · Colostrum + Micronutrients · Healthy, non-smoking men and women aged 40–80 years | 15 mg | 10 weeks | 35 |
| Additional Effects of Nutritional Antioxidant Supplementation on Peripheral Muscle during Pulmonary Rehabilitation in COPD Patients: A Randomized Controlled Trial 2019 · PR antioxidant group · Adults aged 40–78 with stable COPD | 15 mg | 4 weeks | 32 |
| Effect of a mixture of micronutrients, but not of bovine colostrum concentrate, on immune function parameters in healthy volunteers: a randomized placebo-controlled study 2006 · Micronutrients · Healthy, non-smoking men and women aged 40–80 years | 15 mg | 10 weeks | 31 |
| Dietary Intervention With a Targeted Micronutrient Formulation Reduces the Visual Discomfort Associated With Vitreous Degeneration 2021 · active group · Adults aged 18 years and older with primary age-related or myopia-related vitreous floaters | 5 mg | 26 weeks | 31 |
| Magnesium-Zinc-Calcium-Vitamin D Co-supplementation Improves Hormonal Profiles, Biomarkers of Inflammation and Oxidative Stress in Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial 2018 · Magnesium-zinc-calcium-vitamin D co-supplementation · Women with polycystic ovary syndrome (PCOS); age not reported | 8 mg | 12 weeks | 30 |
| A Dermonutrient Containing Special Collagen Peptides Improves Skin Structure and Function: A Randomized, Placebo-Controlled, Triple-Blind Trial Using Confocal Laser Scanning Microscopy on the Cosmetic Effects and Tolerance of a Drinkable Collagen Supplement 2020 · test product (Elasten) · Women aged 40–70 years; healthy, without a stated skin disease | 3 mg | 12 weeks | 30 |
| Yeast Beta-Glucan Supplementation with Multivitamins Attenuates Cognitive Impairments in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial 2023 · active treatment · Adult women with ME/CFS, aged 18 years or older | 7.5 mg | 36 weeks | 29 |
| The Combined Use of Hydroxymethylbutyrate and Branched-Chain Amino Acids to Counteract Uremic Sarcopenia 2026 · FFSMP · Adults aged 45–80, men and women, with end-stage kidney disease receiving hemodialysis | 10 mg | 90 days | 24 |
| The Effect of a Multivitamin and Mineral Supplement on Immune Function in Healthy Older Adults: A Double-Blind, Randomized, Controlled Trial 2020 · Redoxon® Vita Immune (MVM) · Healthy men and women aged 55–75 years | 10 mg | 12 weeks | 21 |
| Mirazid alone or combined with Paromomycin in treating cryptosporidiosis parvum in immunocompetent hospitalized patients 2008 · G1 · Children from a few months to 10 years old with cryptosporidiosis; sex not specified by arm | 20 mg | 2 weeks | 20 |
| Mirazid alone or combined with Paromomycin in treating cryptosporidiosis parvum in immunocompetent hospitalized patients 2008 · G3 · Children from a few months to 10 years old with cryptosporidiosis; sex not specified by arm | 20 mg | 2 weeks | 20 |
| A randomized controlled pilot trial to assess the effectiveness of a specially formulated food supplement and pelvic floor muscle training in women with stress-predominant urinary incontinence 2023 · treatment group · Women with stress or stress-predominant urinary incontinence; ages 53 ± 10 years in this arm | 5 mg | 6 weeks | 18 |
| Carotenoids and antioxidants in age-related maculopathy italian study: multifocal electroretinogram modifications after 1 year 2008 · treated AMD (T-AMD) group · Patients with nonadvanced age-related macular degeneration; mean age 69.4 years | 22.5 mg | 1 year | 15 |
| Effects of Macuprev(®) Supplementation in Age-Related Macular Degeneration: A Double-Blind Randomized Morpho-Functional Study Along 6 Months of Follow-Up 2019 · AMD-M group · Adults with intermediate age-related macular degeneration; 9 male and 21 female enrolled overall, mean age 69.32 years | 16 mg | 26 weeks | 15 |
| A Pilot, Phase II, Observational, Case-Control, 1-Month Study on Asthenopia in Video Terminal Operators without Dry Eye: Contrast Sensitivity and Quality of Life before and after the Oral Consumption of a Fixed Combination of Zinc, L-Carnitine, Extract of Elderberry, Currant and Extract of Eleutherococcus 2021 · group T = treatment · VDT workers of any age and gender, without dry eye and with symptoms of ocular discomfort | 10 mg | 30 days | 15 |
| The effects of antioxidant vitamin supplementation on expiratory flow rates at rest and during exercise 2015 · antioxidant vitamin supplementation (AVS) · healthy nonsmoking adults, 5 men and 5 women, consuming fewer than 5 servings of fruit and vegetables per day | 7.5 mg | 4 weeks | 10 |
| Treatment with supplementary arginine, vitamin C and zinc in patients with pressure ulcers: a randomised controlled trial 2005 · Standard diet plus two high-protein/energy supplements containing additional arginine, vitamin C and zinc · Inpatients aged 37–92 years with stage 2, 3 or 4 pressure ulcers | 30 mg | 3 weeks | — |
| Changes in ventilatory threshold at high altitude: effect of antioxidants 2006 · antioxidant (AO) supplement group · Physically fit males aged 25 ± 5 years exposed to high altitude at 4300 m | 30 mg | 5 weeks | — |
| A micronutrient-fortified seasoning powder reduces morbidity and improves short-term cognitive function, but has no effect on anthropometric measures in primary school children in northeast Thailand: a randomized controlled trial 2008 · seasoning powder fortified with micronutrients · Children aged 5.5–13.4 years in primary schools in northeast Thailand | 5 mg | 31 weeks | — |
| Improving neuropathy scores in type 2 diabetic patients using micronutrients supplementation 2011 · Group MVB · Patients with type 2 diabetes | 20 mg | 120 days | — |
| French adults' cognitive performance after daily supplementation with antioxidant vitamins and minerals at nutritional doses: a post hoc analysis of the Supplementation in Vitamins and Mineral Antioxidants (SU.VI.MAX) trial 2011 · antioxidant supplementation · French adults aged 45–60 years enrolled in the SU.VI.MAX study | 20 mg | 2922 days | — |
| School-based calcium-vitamin D with micronutrient supplementation enhances bone mass in underprivileged Indian premenarchal girls 2012 · Ca+MZ-group · Premenarchal girls aged 8–12 years from low-income groups in Pune, India | 15 mg | 1 year | — |
| Effect of micronutrient supplementation on height velocity of underprivileged girls in comparison with un-supplemented healthy controls 2014 · Ca+MZn+D group (C1) · Underprivileged premenarchal girls aged 8–12 years | 15 mg | 1 year | — |
| The impact of vitamins and/or mineral supplementation on blood pressure in type 2 diabetes 2004 · group MV · People with type 2 diabetes; age and sex not reported | 30 mg | 90 days | 17 |
| Zinc supplementation in prediabetes: A randomized double-blind placebo-controlled clinical trial 2018 · treatment group · Adults with prediabetes; mean age 51.8 years, 43% male, with mean baseline serum zinc concentrations below normal | 20 mg | 1 year | 100 |
| Effect of zinc supplementation on markers of insulin resistance, oxidative stress, and inflammation among prepubescent children with metabolic syndrome 2010 · zinc · Obese prepubescent Iranian children | 20 mg | 8 weeks | 60 |
| [Observation on clinical efficacy of combined therapy of zinc supplement and jinye baidu granule in treating human cytomegalovirus infection] 2005 · high-dose zinc combined group · Patients with positive HCMV-IgM; age and sex not specified | 30 mg | — | 35 |
| [Observation on clinical efficacy of combined therapy of zinc supplement and jinye baidu granule in treating human cytomegalovirus infection] 2005 · moderate-dose zinc combined group · Patients with positive HCMV-IgM; age and sex not specified | 20 mg | — | 35 |
| Oral zinc supplementation reduces the erythropoietin responsiveness index in patients on hemodialysis 2015 · polaprezinc therapy group · Adults aged 20–85 with zinc deficiency undergoing hemodialysis | 34 mg | 1 year | 35 |
| Zinc supplementation ameliorates type 2 diabetes markers through the enhancement of total antioxidant capacity in overweight patients 2023 · zinc group · Overweight patients with type 2 diabetes mellitus | 50 mg | 8 weeks | 35 |
| Antioxidant effect of zinc picolinate in patients with chronic obstructive pulmonary disease 2008 · COPD group · Adults with stable chronic obstructive pulmonary disease; age and sex not specified | 22 mg | 8 weeks | 30 |
| Effect of zinc supplementation on insulin resistance and components of the metabolic syndrome in prepubertal obese children 2009 · zinc group · Prepubertal obese Iranian children; mean age 9.1 ± 1.1 years | 20 mg | 8 weeks | 30 |
| Fatty acid desaturation in red blood cell membranes of patients with type 2 diabetes is improved by zinc supplementation 2020 · zinc supplemented group · Adults with type 2 diabetes; age and sex not reported | 30 mg | 2 years | 30 |
| The effects of zinc supplementation on clinical response and metabolic profiles in pregnant women at risk for intrauterine growth restriction: a randomized, double-blind, placebo-controlled trial 2021 · Zinc supplementation · Pregnant women at risk for intrauterine growth restriction, enrolled at 17 weeks of gestation | 30 mg | 10 weeks | 26 |
| A randomized clinical study to evaluate the possible antifibrotic effect of zinc sulfate in chronic HCV patient receiving direct-acting anti-viral therapy 2025 · Group 2 (the Zinc group) · Adults aged 18–65 with chronic HCV infection and mild or moderate liver fibrosis (stages F1–F2), receiving direct-acting antiviral therapy | 50 mg | 90 days | 25 |
| Effects of Zinc Supplementation on Nutritional Status in Children with Chronic Kidney Disease: A Randomized Trial 2019 · Group A · Children and adolescents aged 1–18 years with chronic kidney disease, regardless of disease stage | 30 mg | 330 days | 24 |
| Effect of zinc supplementation on the antioxidant, copper, and iron status of physically active adolescents 2009 · Zn-supplemented (Zn-SUP) · Physically active male football players, approximately 13 years old | 22 mg | 12 weeks | 21 |
| Zinc supplementation improves bone density in patients with thalassemia: a double-blind, randomized, placebo-controlled trial 2013 · zinc group · Patients with thalassemia major and low bone mass; ages 10–30 years, 21 females across both groups | 25 mg | 548 days | 21 |
| Zinc supplementation reduced DNA breaks in Ethiopian women 2015 · zinc supplement · Non-pregnant women aged 18–50 years from rural Sidama, Ethiopia; the population was considered at high risk of zinc deficiency. | 20 mg | 17 days | 20 |
| The Effect of Zinc Supplementation on Expressed Levels of Peroxisome Proliferator-Activated Receptor Gamma and Glucose Transporter Type 1 Genes in Newborns of Women with Gestational Diabetes Mellitus 2017 · zinc group · pregnant women with gestational diabetes mellitus | 30 mg | 6 weeks | 20 |
| Effect of daily zinc supplementation for 12 weeks on serum thyroid auto-antibody levels in children and adolescents with autoimmune thyroiditis - a randomized controlled trial 2024 · zinc supplementation · Children aged 3–18 years with autoimmune thyroid disease | 25 mg | 12 weeks | 20 |
| Homeostatic regulation of zinc transporters in the human small intestine by dietary zinc supplementation 2005 · zinc supplement · 18 patients with a previous ileostomy and no symptoms of inflammatory bowel disease; age and sex not reported | 25 mg | 2 weeks | 18 |
| Effects of Zinc and Selenium Supplementation on Thyroid Function in Overweight and Obese Hypothyroid Female Patients: A Randomized Double-Blind Controlled Trial 2015 · Zn + placebo (ZP) · Overweight or obese female patients with hypothyroidism | 30 mg | 12 weeks | 17 |
| Effect of probiotic L. plantarum IS-10506 and zinc supplementation on humoral immune response and zinc status of Indonesian pre-school children 2014 · zinc · Indonesian children aged 12–24 months | 20 mg | 90 days | 12 |
| Effects of zinc supplementation on blood rheology during exercise 1999 · zinc · Healthy male volunteers, age 26 ± 1.3 years; no diagnosed condition stated | 20 mg | 7 days | 10 |
| Effects of oral zinc gluconate on glucose effectiveness and insulin sensitivity in humans 1995 · zinc gluconate · seven healthy volunteers | 40 mg | 1 day | 7 |
| Zinc sulfate inhibits the enterohepatic cycling of unconjugated bilirubin in subjects with Gilbert's syndrome 2002 · acute treatment of normal healthy volunteers · Normal healthy volunteers; age and sex not reported | 40 mg | 1 day | 5 |
| Antioxidant effects of zinc supplementation in Tunisians with type 2 diabetes mellitus 2003 · zinc-supplemented group · Tunisian adults with type 2 diabetes mellitus and HbA1c >7.5% | 30 mg | 26 weeks | — |
| Zinc sulfate inhibits the enterohepatic cycling of unconjugated bilirubin in subjects with Gilbert's syndrome 2002 · acute treatment · Patients with Gilbert's syndrome; age and sex not reported | 40 mg | 1 day | — |
| Zinc supplementation to HIV-1-infected pregnant women: effects on maternal anthropometry, viral load, and early mother-to-child transmission 2006 · zinc · HIV-1-infected pregnant women, 12–27 weeks of gestation | 25 mg | 22 weeks | — |
| Iron and/or zinc supplementation did not reduce blood lead concentrations in children in a randomized, placebo-controlled trial 2006 · Zinc · First-grade children attending schools within 3.5 km of a metal foundry; lead-exposed | 30 mg | 26 weeks | — |
| Effect of zinc supplementation on serum leptin levels and insulin resistance of obese women 2006 · zinc-supplemented group · Women aged 25–45 with obesity and normal glucose tolerance | 30 mg | 4 weeks | — |
| Inflammation markers predict zinc transporter gene expression in women with type 2 diabetes mellitus 2013 · zinc alone · postmenopausal women with type 2 diabetes mellitus | 40 mg | 12 weeks | — |
| Effect of zinc supplementation on serum antibody titers to heat shock protein 27 in patients with thalassemia major 2014 · zinc (case) group · Patients aged 8–18 years with transfusion-dependent beta-thalassemia major | 30 mg | 274 days | — |
| Zinc supplementation improves anticancer activity of monocytes in type-2 diabetic patients with metabolic syndrome 2014 · zinc-treated group · Patients with type 2 diabetes mellitus and metabolic syndrome; age and sex not reported | 30 mg | 8 weeks | — |
| Zinc or albendazole attenuates the progression of environmental enteropathy: a randomized controlled trial 2014 · zinc group · Asymptomatic rural Malawian children aged 1–3 years at high risk for environmental enteropathy | 20 mg | 2 weeks | — |
| The changes of zinc transporter ZnT gene expression in response to zinc supplementation in obese women 2014 · zinc group · Obese women aged 18–28 years | 30 mg | 8 weeks | — |
| Zinc supplementation for improving glucose handling in pre-diabetes: A double blind randomized placebo controlled pilot study 2016 · intervention group · People with prediabetes; age range and sex not reported | 30 mg | 26 weeks | — |
| The effect of selenium and zinc on CD4(+) count and opportunistic infections in HIV/AIDS patients: a randomized double blind trial 2020 · zinc · HIV-positive patients receiving combination antiretroviral therapy with CD4(+) count above 200 per cubic millimeter | 50 mg | 26 weeks | — |
| Effects of zinc supplementation on superoxide dismutase activity and gene expression, and metabolic parameters in overweight type 2 diabetes patients: A randomized, double-blind, controlled trial 2019 · zinc group · Overweight patients with type 2 diabetes; age and sex not specified | 50 mg | 8 weeks | — |
| Effects of zinc supplementation on serum adiponectin concentration and glycemic control in patients with type 2 diabetes 2019 · zinc group · Patients aged 30–60 years with type 2 diabetes | 30 mg | 12 weeks | — |
| Zinc supplementation improves glucose homeostasis in patients with β-thalassemia major complicated with diabetes mellitus: A randomized controlled trial 2020 · intervention group · Pediatric patients with β-thalassemia major complicated with diabetes mellitus | 40 mg | 12 weeks | — |
| The Effect of Zinc Supplementation on Steatosis Severity and Liver Function Enzymes in Overweight/Obese Patients with Mild to Moderate Non-alcoholic Fatty Liver Following Calorie-Restricted Diet: a Double-Blind, Randomized Placebo-Controlled Trial 2020 · zinc supplement group · Overweight or obese patients with mild to moderate non-alcoholic fatty liver disease | 30 mg | 12 weeks | — |
| Daily Preventive Zinc Supplementation Decreases Lymphocyte and Eosinophil Concentrations in Rural Laotian Children from Communities with a High Prevalence of Zinc Deficiency: Results of a Randomized Controlled Trial 2020 · therapeutic dispersible zinc tablets (TZ) · Children aged 6–23 months in rural Laotian communities with a high prevalence of zinc deficiency who had diarrhea episodes | 20 mg | 10 days | — |
| Effect of zinc supplementation on blood glucose level in different age groups of diabetes type 2 2023 · Group 1 (Treatment group) · Adults aged 30–70 years with type 2 diabetes, divided into age categories 30–50 and 51–70 years | 20 mg | 60 days | — |
| Effects of Zinc Supplementation on Inflammatory Status and Nonalcoholic Steatohepatitis in Overweight or Obese Children: a Randomized Clinical Trial 2024 · zinc group · Children aged 10–18 years who were overweight or obese and had nonalcoholic steatohepatitis (NASH) | 30 mg | 16 weeks | — |
| Effects of zinc supplementation on the phagocytic functions of polymorphonuclears in patients with inflammatory rheumatic diseases 1994 · zinc supplementation · Patients with inflammatory rheumatic diseases | 45 mg | 60 days | — |
| Zinc supplementation and plasma lipid peroxides in an elderly population 1997 · zinc · elderly residents of a public home in Rome, described as healthy | 25 mg | 90 days | — |
| Competitive reverse transcriptase-polymerase chain reaction shows that dietary zinc supplementation in humans increases monocyte metallothionein mRNA levels 1997 · zinc-supplemented subjects · Human subjects; age, sex, and health condition not specified | 50 mg | 15 days | — |
| Associations among dietary zinc intakes and biomarkers of zinc status before and after a zinc supplementation program in Guatemalan schoolchildren 2013 · zinc group · Children aged 6–11 years from low-income schools in Guatemala City, presumed to be at risk for zinc deficiency | 10 mg | 26 weeks | 346 |
| A randomized controlled study of the impact of dietary zinc supplementation in the management of children with protein-energy malnutrition in Lesotho. II: Special investigations 2003 · zinc · Children aged 6–60 months with protein-energy malnutrition and biochemical zinc deficiency, admitted to Queen Elizabeth II Hospital in Lesotho | 10 mg | 90 days | 150 |
| Zinc Supplementation, Inflammation, and Gut Integrity Markers in HIV Infection: A Randomized Placebo-Controlled Trial 2025 · zinc treatment group · Adults with zinc deficiency living with HIV and receiving stable antiretroviral therapy | 90 mg | 24 weeks | 63 |
| The influence of inflammation on plasma zinc concentration in apparently healthy, HIV+ Kenyan adults and zinc responses after a multi-micronutrient supplement 2010 · food plus micronutrient capsule (MN) · Apparently healthy adults who tested positive twice for HIV and had not reached stage IV or clinical AIDS | 15 mg | — | 43 |
| Effects of zinc supplementation on plasma copper/zinc ratios, oxidative stress, and immunological status in hemodialysis patients 2013 · Zn supplementation group · Adults under 70 with chronic renal failure receiving hemodialysis and low plasma zinc concentrations | 11 mg | 8 weeks | 40 |
| Zinc supplementation during lactation: effects on maternal status and milk zinc concentrations 1995 · zinc supplement (ZS) · lactating women | 15 mg | 30 weeks | 40 |
| Antioxidant effect of zinc supplementation on both plasma and cellular red-ox status markers in a group of elderly Italian population 2014 · 15 mg Zn group · Healthy Italian adults aged 70–85 years; men and women | 15 mg | 26 weeks | 37 |
| Brief Report: Zinc Supplementation and Inflammation in Treated HIV 2019 · high-dose arm · Adults aged 18 years or older with HIV-1 on stable antiretroviral therapy and documented zinc deficiency | 90 mg | 16 weeks | 27 |
| Zinc Absorption from Micronutrient Powders Is Low in Bangladeshi Toddlers at Risk of Environmental Enteric Dysfunction and May Increase Dietary Zinc Requirements 2019 · 10 mg MNP dose group · Bangladeshi toddlers aged 18–24 months, at risk of environmental enteric dysfunction and with length-for-age z scores between −1.25 and −3.0 | 10 mg | 1 day | 19 |
| Zinc Absorption from Micronutrient Powders Is Low in Bangladeshi Toddlers at Risk of Environmental Enteric Dysfunction and May Increase Dietary Zinc Requirements 2019 · 15 mg MNP dose group · Bangladeshi toddlers aged 18–24 months, at risk of environmental enteric dysfunction and with length-for-age z scores between −1.25 and −3.0 | 15 mg | 1 day | 17 |
| Metabolic adaptations to low zinc intakes in premenarcheal girls 2004 · High zinc intake · Healthy premenarcheal girls aged 9–14 years | 12 mg | 2 weeks | 16 |
| Long-term moderate zinc supplementation increases exchangeable zinc pool masses in late-middle-aged men: the Zenith Study 2005 · 15 mg Zn group · Healthy, late-middle-aged men | 15 mg | 26 weeks | 16 |
| Glycoprotein Matrix Zinc Exhibits Improved Absorption: A Randomized Crossover Trial 2024 · GPM (glycoprotein matrix-bound zinc) · Healthy men and women aged 18–55 years, normal body weight and recreationally active | 11 mg | 1 day | 16 |
| Glycoprotein Matrix Zinc Exhibits Improved Absorption: A Randomized Crossover Trial 2024 · USP (U.S. Pharmacopeia-grade zinc oxide) · Healthy men and women aged 18–55 years, normal body weight and recreationally active | 11 mg | 1 day | 16 |
| Zinc absorption by young adults from supplemental zinc citrate is comparable with that from zinc gluconate and higher than from zinc oxide 2014 · zinc citrate · Healthy men and women aged 18–45 years; not selected for a diagnosed condition | 10 mg | 1 day | 15 |
| Zinc absorption by young adults from supplemental zinc citrate is comparable with that from zinc gluconate and higher than from zinc oxide 2014 · zinc gluconate · Healthy men and women aged 18–45 years; not selected for a diagnosed condition | 10 mg | 1 day | 15 |
| Zinc absorption by young adults from supplemental zinc citrate is comparable with that from zinc gluconate and higher than from zinc oxide 2014 · zinc oxide · Healthy men and women aged 18–45 years; not selected for a diagnosed condition | 10 mg | 1 day | 15 |
| The pharmacokinetics of zinc from zinc gluconate: a comparison with zinc oxide in healthy men 2005 · zinc oxide · healthy men aged 21–31 years | 17.4 mg | 2 weeks | 12 |
| A bioavailability study comparing two oral formulations containing zinc (Zn bis-glycinate vs. Zn gluconate) after a single administration to twelve healthy female volunteers 2007 · zinc bis-glycinate · 12 healthy female volunteers; age not stated | 15 mg | 1 day | 12 |
| A bioavailability study comparing two oral formulations containing zinc (Zn bis-glycinate vs. Zn gluconate) after a single administration to twelve healthy female volunteers 2007 · zinc gluconate · 12 healthy female volunteers; age not stated | 15 mg | 1 day | 12 |
| Effect of dietary phytic acid on zinc absorption in the healthy elderly, as assessed by serum concentration curve tests 1998 · 0 g/200 ml phytic acid · Healthy elderly adults aged 71–78 years | 50 mg | 1 day | 10 |
| Effect of dietary phytic acid on zinc absorption in the healthy elderly, as assessed by serum concentration curve tests 1998 · 0.26 g/200 ml phytic acid · Healthy elderly adults aged 71–78 years | 50 mg | 1 day | 10 |
| Effect of dietary phytic acid on zinc absorption in the healthy elderly, as assessed by serum concentration curve tests 1998 · 0 g/200 ml phytic acid · Healthy young adults aged 23–43 years | 50 mg | 1 day | 10 |
| Effect of dietary phytic acid on zinc absorption in the healthy elderly, as assessed by serum concentration curve tests 1998 · 0.26 g/200 ml phytic acid · Healthy young adults aged 23–43 years | 50 mg | 1 day | 10 |
| Effect of dietary phytic acid on zinc absorption in the healthy elderly, as assessed by serum concentration curve tests 1998 · 0 g/200 ml phytic acid · Healthy young adults aged 23–43 years | 50 mg | 1 day | 10 |
| Effect of dietary phytic acid on zinc absorption in the healthy elderly, as assessed by serum concentration curve tests 1998 · 0.13 g/200 ml phytic acid · Healthy young adults aged 23–43 years | 50 mg | 1 day | 10 |
| Effect of dietary phytic acid on zinc absorption in the healthy elderly, as assessed by serum concentration curve tests 1998 · 0 g/200 ml phytic acid · Healthy elderly adults aged 71–78 years | 50 mg | 1 day | 9 |
| Effect of dietary phytic acid on zinc absorption in the healthy elderly, as assessed by serum concentration curve tests 1998 · 0.13 g/200 ml phytic acid · Healthy elderly adults aged 71–78 years | 50 mg | 1 day | 9 |
| Vitamin A and zinc supplementation of preschool children 1999 · Zn · Children aged 22 to 66 months in Belize, selected for low or marginal serum micronutrient concentrations | 10 mg | 26 weeks | — |
| Iron and zinc supplementation improves indicators of vitamin A status of Mexican preschoolers 2000 · zinc plus iron · Rural Mexican children aged 18–36 months | 20 mg | 26 weeks | — |
| Redistribution of vitamin A after iron supplementation in Indonesian infants 2003 · 10 mg Zn · Indonesian infants aged 4 months | 10 mg | 26 weeks | — |
| A community-based randomized controlled trial of iron and zinc supplementation in Indonesian infants: interactions between iron and zinc 2003 · Zn group · Indonesian infants aged 6–12 months | 10 mg | 26 weeks | — |
| Efficacy of combined iron and zinc supplementation on micronutrient status and growth in Vietnamese infants 2006 · Zn-group · Breast-fed infants aged 4–7 months in rural Vietnam | 10 mg | 26 weeks | — |
| Iron and zinc supplementation improved iron and zinc status, but not physical growth, of apparently healthy, breast-fed infants in rural communities of northeast Thailand 2006 · zinc supplementation alone · Apparently healthy, breast-fed Thai infants aged 4–6 months | 10 mg | 26 weeks | — |
| Age- and sex-dependent effects of long-term zinc supplementation on essential trace element status and lipid metabolism in European subjects: the Zenith Study 2007 · 15 mg zinc group · Healthy adults aged 55–70 or 70–85 years | 15 mg | 26 weeks | — |
| Effect of zinc supplementation on vitamin status of middle-aged and older European adults: the ZENITH study 2008 · 15 mg Zn/day group · Healthy men and women aged 55–70 or 70–85 years | 15 mg | 26 weeks | — |
| Dose-response trial of prophylactic zinc supplements, with or without copper, in young Ecuadorian children at risk of zinc deficiency 2008 · 10 mg Zn as zinc sulfate · Ecuadorian children aged 12–30 months at baseline with length-for-age z scores below −1.3, at risk of zinc deficiency | 10 mg | 26 weeks | — |
| Effect of zinc and iron supplementation on indicators of iron, zinc and vitamin A status of primary school children 2007 · iron+ zinc · 11-year-old primary school children | 20 mg | 120 days | — |
| Plasma zinc concentration responds rapidly to the initiation and discontinuation of short-term zinc supplementation in healthy men 2010 · 10 mg Zn/d · Healthy males aged 19–54 years | 10 mg | 3 weeks | — |
| Effects of zinc supplementation on antioxidant status and lipid peroxidation in hemodialysis patients 2013 · Zinc group (crossover supplement phase) · Hemodialysis patients | 100 mg | 60 days | — |
| Effects of zinc supplementation on serum zinc and leptin levels, BMI, and body composition in hemodialysis patients 2014 · supplemented group · Hemodialysis patients; age and sex distribution not specified | 100 mg | 60 days | — |
| Zinc Supplementation Initiated Prior to or During Pregnancy Modestly Impacted Maternal Status and High Prevalence of Hypozincemia in Pregnancy and Lactation: The Women First Preconception Maternal Nutrition Trial 2024 · Arm 1 (PreconceptionSupplement) · Nonpregnant women enrolled in Guatemala, India, and Pakistan who became pregnant; supplementation began before conception and continued through delivery. | 15 mg | — | — |
| Zinc Supplementation Initiated Prior to or During Pregnancy Modestly Impacted Maternal Status and High Prevalence of Hypozincemia in Pregnancy and Lactation: The Women First Preconception Maternal Nutrition Trial 2024 · Arm 2 (PrenatalSupplement) · Women enrolled before pregnancy in Guatemala, India, and Pakistan; supplementation began around 12 weeks of gestation and continued through delivery. | 15 mg | — | — |
| Effects of oral administration of zinc and diiodohydroxyquinolein on plasma zinc levels of uremic patients 1995 · group 2 · Uremic patients with chronic renal failure; age and sex not reported | 100 mg | 2 weeks | — |
| Effects of oral administration of zinc and diiodohydroxyquinolein on plasma zinc levels of uremic patients 1995 · group 4 · Uremic patients with chronic renal failure; age and sex not reported | 100 mg | 2 weeks | — |
| Urinary zinc as a marker of zinc intake: results of a supplementation trial in free-living men 1994 · 100 mg zinc · Adult male volunteers; age range and health status not specified | 100 mg | 7 days | — |
| Growth and body composition of periurban Guatemalan children in relation to zinc status: a longitudinal zinc intervention trial 1993 · zinc-supplement group · Periurban Guatemalan children, mean age 81.5 months; zinc status not specified | 10 mg | 90 days | — |
| [Vitrum osteomag in prevention of osteoporosis in postmenopausal women: results of the comparative open multicenter trial] 2004 · Group 1: Vitrum Osteomag · Postmenopausal women with osteopenia; age range not reported | 15 mg | 1 year | 125 |
| Calcium and vitamin D fortified milk reduces bone turnover and improves bone density in postmenopausal women over 1 year 2018 · intervention · Chinese postmenopausal women in Malaysia; mean age 59 years | 2.4 mg | 1 year | 61 |
| Spinal bone loss in postmenopausal women supplemented with calcium and trace minerals 1994 · calcium plus trace minerals · Healthy postmenopausal women, mean age 66 years | 15 mg | 2 years | — |
| Combination oral antioxidant supplementation reduces blood pressure 1997 · antioxidants · Hypertensive and normotensive adult outpatients; 21 were attending for hypertension treatment and 17 were normotensive outpatients with minor gastrointestinal complaints. | 200 mg | 8 weeks | — |
| Zinc Supplementation Increases Procollagen Type 1 Amino-Terminal Propeptide in Premenarcheal Girls: A Randomized Controlled Trial 2015 · zinc tablet · Premenarcheal girls aged 9–11 years | 9 mg | 4 weeks | 75 |
| Zinc supplementation for four months does not affect plasma copper concentration in infants 2004 · zinc group (Z) · infants | 10 mg | 120 days | 61 |
| [Observation on clinical efficacy of combined therapy of zinc supplement and jinye baidu granule in treating human cytomegalovirus infection] 2005 · low-dose zinc combined group · Patients with positive HCMV-IgM; age and sex not specified | 10 mg | — | 35 |
| Effects of selenium and zinc supplementation on nutritional status in patients with cancer of digestive tract 2001 · selenium and zinc treated group · Adults with digestive tract cancer receiving chemotherapy; median age 55 years (range 46–61) | 21 mg | 50 days | 30 |
| Effects of short-term zinc supplementation on cellular immunity, respiratory symptoms, and growth of malnourished Equadorian children 1996 · supplemented (S) group · Malnourished children aged 12–59 months | 10 mg | 60 days | 25 |
| Effects of Zinc Supplementation on Nutritional Status in Children with Chronic Kidney Disease: A Randomized Trial 2019 · Group B · Children and adolescents aged 1–18 years with chronic kidney disease, regardless of disease stage | 15 mg | 330 days | 24 |
| Renal effects of metallothionein induction by zinc in vitro and in vivo 2017 · zinc group · Adults with moderately impaired kidney function receiving low-osmolar contrast medium; age 18 years or older | 60 mg | 2 days | 18 |
| Effects of Zinc and Selenium Supplementation on Thyroid Function in Overweight and Obese Hypothyroid Female Patients: A Randomized Double-Blind Controlled Trial 2015 · Zn + Se (ZS) · Overweight or obese female patients with hypothyroidism | 30 mg | 12 weeks | 17 |
| The impact of vitamin and/or mineral supplementation on lipid profiles in type 2 diabetes 2004 · group M · Adults with type 2 diabetes; age and sex not reported | 30 mg | 90 days | 16 |
| Comparison of the effects of vitamins and/or mineral supplementation on glomerular and tubular dysfunction in type 2 diabetes 2005 · group M · Patients with type 2 diabetes; age range and sex not specified | 30 mg | 90 days | 16 |
| Oral zinc supplementation decreases the serum iron concentration in healthy schoolchildren: a pilot study 2014 · experimental group · Healthy boys and girls aged 8–9 years | 10 mg | 90 days | 15 |
| Zinc supplementation does not alter sensitive biomarkers of copper status in healthy boys 2013 · 10 mg zinc · Healthy boys aged 6–8 years | 10 mg | 122 days | 9 |
| Zinc supplementation does not alter sensitive biomarkers of copper status in healthy boys 2013 · 15 mg zinc · Healthy boys aged 6–8 years | 15 mg | 122 days | 8 |
| Metallothionein mRNA in monocytes and peripheral blood mononuclear cells and in cells from dried blood spots increases after zinc supplementation of men 2000 · zinc supplementation · men; age and health condition not stated | 15 mg | 10 days | — |
| Zinc sulfate inhibits the enterohepatic cycling of unconjugated bilirubin in subjects with Gilbert's syndrome 2002 · chronic treatment · Patients with Gilbert's syndrome; age and sex not reported | 100 mg | 7 days | — |
| Safety and efficacy of zinc supplementation for children with HIV-1 infection in South Africa: a randomised double-blind placebo-controlled trial 2005 · zinc-supplemented group · Children with HIV-1 infection; age and sex not specified | 10 mg | 26 weeks | — |
| Effects of melatonin and zinc on glycemic control in type 2 diabetic patients poorly controlled with metformin 2006 · melatonin and zinc alone · Patients with type 2 diabetes mellitus and inadequate response to metformin | 50 mg | 90 days | — |
| Effects of melatonin and zinc on glycemic control in type 2 diabetic patients poorly controlled with metformin 2006 · melatonin and zinc with metformin · Patients with type 2 diabetes mellitus and inadequate response to metformin | 50 mg | 90 days | — |
| Combined iron and zinc supplementation in infants improved iron and zinc status, but interactions reduced efficacy in a multicountry trial in southeast Asia 2007 · zinc · Infants aged 4–6 months | 10 mg | 26 weeks | — |
| The efficacy of micronutrient supplementation in reducing the prevalence of anaemia and deficiencies of zinc and iron among adolescents in Sri Lanka 2008 · zinc-only group · Schoolchildren aged 12–16 years; the study reports a high prevalence of low serum zinc at baseline. | 14 mg | 24 weeks | — |
| Paraoxonase enzyme activity is enhanced by zinc supplementation in hemodialysis patients 2012 · treatment (case) group · Hemodialysis patients; age and sex not reported | 100 mg | 60 days | — |
| Effect of zinc and vitamin A supplementation on immune responses in Indonesian pre-schoolers 2020 · zinc only · Indonesian preschool children aged 2–5 years | 10 mg | 120 days | — |
| Zinc supplementation restores plasma concentrations of zinc and thymulin in patients with Crohn's disease 1993 · 60 mg/day ZnSO4 · Patients with Crohn's disease in clinical remission and decreased plasma zinc and active thymulin concentrations | 60 mg | 90 days | — |
| Plasma and Nail Zinc Concentrations, But Not Hair Zinc, Respond Positively to Two Different Forms of Preventive Zinc Supplementation in Young Laotian Children: a Randomized Controlled Trial 2021 · PZ group (daily preventive zinc supplement tablets) · Children aged 6–23 months in Lao PDR | 7 mg | 36 weeks | 128 |
| Plasma and Nail Zinc Concentrations, But Not Hair Zinc, Respond Positively to Two Different Forms of Preventive Zinc Supplementation in Young Laotian Children: a Randomized Controlled Trial 2021 · MNP group (daily preventive multiple micronutrient powder) · Children aged 6–23 months in Lao PDR | 10 mg | 36 weeks | 123 |
| A study of the effect of oral zinc supplementation during pregnancy on pregnancy outcome 1993 · Group B · Pregnant women in different trimesters | 200 mg | — | 106 |
| Zinc influences innate immune responses in children with enterotoxigenic Escherichia coli-induced diarrhea 2010 · zinc treatment plus supplementation (ZT+S) · Children aged 6–24 months with ETEC-induced diarrhea | 30 mg | 100 days | 74 |
| Zinc supplementation and the effects on metabolic status in gestational diabetes: A randomized, double-blind, placebo-controlled trial 2015 · Zinc supplementation · Primigravida women aged 18–40 diagnosed with gestational diabetes | 233 mg | 6 weeks | 29 |
| Effect of daily supplementation with iron and zinc on iron status of childbearing age women 2015 · group 2 · Women aged 18–45 years of childbearing age | 30 mg | 90 days | 26 |
| Effects of zinc supplementation on markers of insulin resistance and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial 2015 · zinc supplements · Women aged 18–40 years diagnosed with polycystic ovary syndrome | 220 mg | 8 weeks | 26 |
| Zinc Supplementation and the Effects on Pregnancy Outcomes in Gestational Diabetes: a Randomized, Double-blind, Placebo-controlled Trial 2016 · zinc gluconate group · Pregnant women with gestational diabetes; age and sex beyond the stated pregnancy population not specified | 233 mg | 6 weeks | 25 |
| Zinc Absorption from Micronutrient Powders Is Low in Bangladeshi Toddlers at Risk of Environmental Enteric Dysfunction and May Increase Dietary Zinc Requirements 2019 · 5 mg MNP dose group · Bangladeshi toddlers aged 18–24 months, at risk of environmental enteric dysfunction and with length-for-age z scores between −1.25 and −3.0 | 5 mg | 1 day | 19 |
| Metabolic adaptations to low zinc intakes in premenarcheal girls 2004 · Low zinc intake · Healthy premenarcheal girls aged 9–14 years | 4 mg | 2 weeks | 16 |
| The effect of zinc-supplemented bread consumption on school children with asymptomatic zinc deficiency 1998 · zinc-supplemented group · 7- to 11-year-old children with asymptomatic zinc deficiency | 2 mg/kg | 90 days | 12 |
| Effects of dietary zinc depletion on seminal volume and zinc loss, serum testosterone concentrations, and sperm morphology in young men 1992 · 2.5 mg Zn/d · Young men; age range and health condition not reported | 2.5 mg | 5 weeks | 11 |
| Effects of dietary zinc depletion on seminal volume and zinc loss, serum testosterone concentrations, and sperm morphology in young men 1992 · 3.4 mg Zn/d · Young men; age range and health condition not reported | 3.4 mg | 5 weeks | 11 |
| The effects of zinc supplementation on serum zinc concentration and protein catabolic rate in hemodialysis patients 2000 · zinc-supplemented group · Adults receiving maintenance hemodialysis selected for low protein catabolic rate; serum zinc was below the normal range at baseline | 2.2 mg | 90 days | — |
| The effect of five-year zinc supplementation on serum zinc, serum cholesterol and hematocrit in persons randomly assigned to treatment group in the age-related eye disease study: AREDS Report No. 7 2002 · zinc · Adults aged 55–80 years with early-to-late age-related macular degeneration | 80 mg | 5 years | — |
| A community-based randomized controlled trial of iron and zinc supplementation in Indonesian infants: interactions between iron and zinc 2003 · Fe+Zn group · Indonesian infants aged 6–12 months | 10 mg | 26 weeks | — |
| Zinc plus beta-carotene supplementation of pregnant women is superior to beta-carotene supplementation alone in improving vitamin A status in both mothers and infants 2004 · zinc · Pregnant women; age and specific condition not stated | 30 mg | — | — |
| Efficacy of combined iron and zinc supplementation on micronutrient status and growth in Vietnamese infants 2006 · Fe-Zn group · Breast-fed infants aged 4–7 months in rural Vietnam | 10 mg | 26 weeks | — |
| Dose-response trial of prophylactic zinc supplements, with or without copper, in young Ecuadorian children at risk of zinc deficiency 2008 · 3 mg Zn as zinc sulfate · Ecuadorian children aged 12–30 months at baseline with length-for-age z scores below −1.3, at risk of zinc deficiency | 3 mg | 26 weeks | — |
| Dose-response trial of prophylactic zinc supplements, with or without copper, in young Ecuadorian children at risk of zinc deficiency 2008 · 7 mg Zn as zinc sulfate · Ecuadorian children aged 12–30 months at baseline with length-for-age z scores below −1.3, at risk of zinc deficiency | 7 mg | 26 weeks | — |
| Short-term zinc supplementation with dispersible tablets or zinc sulfate solution yields similar positive effects on plasma zinc concentration of young children in Burkina Faso: a randomized controlled trial 2012 · zinc sulfate dispersible tablet group · Children aged 6–23 months in Burkina Faso | 5 mg | 3 weeks | — |
| Short-term zinc supplementation with dispersible tablets or zinc sulfate solution yields similar positive effects on plasma zinc concentration of young children in Burkina Faso: a randomized controlled trial 2012 · zinc solution group · Children aged 6–23 months in Burkina Faso | 5 mg | 3 weeks | — |
| Associations between intestinal mucosal function and changes in plasma zinc concentration following zinc supplementation 2013 · dispersible Zn tablet (ZnTab) · Breastfed infants and young children aged 6–23 months in rural Burkina Faso | 5 mg | 3 weeks | — |
| Associations between intestinal mucosal function and changes in plasma zinc concentration following zinc supplementation 2013 · liquid Zn supplement (ZnLiq) · Breastfed infants and young children aged 6–23 months in rural Burkina Faso | 5 mg | 3 weeks | — |
| Effect of zinc supplementation on serum zinc and calcium levels in postmenopausal osteoporotic women in Tabriz, Islamic Republic of Iran 2013 · intervention group · Postmenopausal women with osteoporosis referred to a rheumatology clinic; age range not reported | 220 mg | 60 days | — |
| Absorbed zinc and exchangeable zinc pool size are greater in Pakistani infants receiving traditional complementary foods with zinc-fortified micronutrient powder 2014 · MNP+Zn group · 6-month-old Pakistani infants receiving traditional complementary foods | 10 mg | 1 year | — |
| Efficacy of highly bioavailable zinc from fortified water: a randomized controlled trial in rural Beninese children 2015 · Zn+filter · Rural Beninese school children; age and sex not specified | 2.8 mg | 20 weeks | — |
| Efficacy of zinc supplementation on serum calprotectin, inflammatory cytokines and outcome in neonatal sepsis - a randomized controlled trial 2017 · zinc group · neonates with clinical signs suggestive of sepsis and at least two positive screening tests | 6 mg/kg | 10 days | — |
| Effect of 6 month supplementation with different combinations of an association of antioxidant nutrients on biochemical parameters and markers of the antioxidant defence system in the elderly. The Geriatrie/Min.Vit.Aox Network 1996 · T (trace elements) · Elderly nursing-home residents aged 65–103 years who were long-term hospitalized | 20 mg | 26 weeks | — |
| Effect of a two-year supplementation with low doses of antioxidant vitamins and/or minerals in elderly subjects on levels of nutrients and antioxidant defense parameters 1997 · mineral group · Hospitalized adults older than 65 years; baseline deficiencies of zinc and selenium were common | 20 mg | 2 years | — |
| Omega-3 supplementation combined with anti-vascular endothelial growth factor lowers vitreal levels of vascular endothelial growth factor in wet age-related macular degeneration 2014 · Group 2 (Vitalux AREDS) · Adults with active wet age-related macular degeneration who had previously received anti-VEGF treatment | 25 mg | — | 10 |
| Effects of zinc supplementation on 1- to 5-year old children 2006 · supplementation group · Children aged 12 to 59 months included in the National Child Nutritional Program | 10 mg | 120 days | 28 |
| The effect of oral zinc sulfate supplementation on hospitalized infants with hyperbilirubinemia: a double-blind randomized clinical trial 2024 · zinc sulfate group · Term infants aged 37–42 weeks’ gestation admitted to a neonatal intensive care unit with hyperbilirubinemia and requiring phototherapy | 1 mg/kg | — | 160 |
| Zinc Supplementation in Preterm Neonates with Jaundice: Is it Beneficial? 2021 · group 1 · Preterm neonates with jaundice | 1.2 mg/kg | 10 days | 100 |
| Compliance with home-based fortification strategies for delivery of iron and zinc: its effect on haematological and growth markers among 6-24 months old children in north India 2014 · Sprinkle and nutrition education (Mp) · Children aged 6–24 months in North Delhi, India; children were not selected for a diagnosed condition or documented nutrient deficiency. | 10 mg | 26 weeks | 97 |
| Weekly iron supplementation does not block increases in serum zinc due to weekly zinc supplementation in Bangladeshi infants 2005 · 20 mg zinc · 6-month-old Bangladeshi infants | 2.86 mg | 26 weeks | 83 |
| Zinc supplementation inhibits complement activation in age-related macular degeneration 2014 · Zinc and copper supplement · Adults with age-related macular degeneration; mean age 73.9 years | 50 mg | 90 days | 72 |
| Effect of Three Different Zinc Lactate-Added Tablets on Volatile Sulfur Compounds - A Comparative Study 2025 · 0.7 g test tablet · People with oral volatile sulfur compounds (VSC) of at least 75 ppb at baseline | 510 mcg | 1 day | 30 |
| Effect of Three Different Zinc Lactate-Added Tablets on Volatile Sulfur Compounds - A Comparative Study 2025 · 1 g test tablet · People with oral volatile sulfur compounds (VSC) of at least 75 ppb at baseline | 510 mcg | 1 day | 30 |
| Effect of Three Different Zinc Lactate-Added Tablets on Volatile Sulfur Compounds - A Comparative Study 2025 · 2.1 g test tablet · People with oral volatile sulfur compounds (VSC) of at least 75 ppb at baseline | 510 mcg | 1 day | 30 |
| The Effects of Zinc Sulfate Supplementation on Serum Copeptin, C-Reactive Protein and Metabolic Markers in Zinc-Deficient Diabetic Patients on Hemodialysis: A Randomized, Double-Blind, Placebo-Controlled Trial 2022 · Zn supplement group · Zinc-deficient diabetic patients on hemodialysis | 220 mg | 8 weeks | 21 |
| A moderate increase in dietary zinc reduces DNA strand breaks in leukocytes and alters plasma proteins without changing plasma zinc concentrations 2017 · Moderate zinc, MP2 · Healthy men aged 19–45 years with BMI 18–30 | 4 mg | 4 weeks | 18 |
| Coadministration of atazanavir-ritonavir and zinc sulfate: impact on hyperbilirubinemia and pharmacokinetics 2013 · Zinc sulfate group · Male patients with HIV, stable on atazanavir/ritonavir-containing regimens and with total bilirubin above 25 mmol/liter | 125 mg | 2 weeks | 16 |
| An explorative study of non-invasive ultra-weak photon emission and the anti-oxidative influence of oral zinc sulphate in light-sensitive patients with erythropoietic protoporphyria 2012 · zinc treatment · 14 patients with erythropoietic protoporphyria and light sensitivity; age and sex not reported | 600 mg | — | 14 |
| Effect of oral zinc supplementation on metallothionein and superoxide dismutase concentrations in patients with inflammatory bowel disease 1994 · oral zinc supplementation · 14 patients with inactive to moderately active inflammatory bowel disease and low plasma zinc | 300 mg | 4 weeks | 14 |
| The effect of staggered administration of zinc sulfate on the pharmacokinetics of oral cephalexin 2012 · Cephalexin concomitantly with zinc · Healthy volunteers; age and sex not reported | 250 mg | 1 day | 12 |
| The effect of staggered administration of zinc sulfate on the pharmacokinetics of oral cephalexin 2012 · Zinc 3h after cephalexin · Healthy volunteers; age and sex not reported | 250 mg | 1 day | 12 |
| The effect of staggered administration of zinc sulfate on the pharmacokinetics of oral cephalexin 2012 · Zinc 3h before cephalexin · Healthy volunteers; age and sex not reported | 250 mg | 1 day | 12 |
| Effects of dietary zinc depletion on seminal volume and zinc loss, serum testosterone concentrations, and sperm morphology in young men 1992 · 4.4 mg Zn/d · Young men; age range and health condition not reported | 4.4 mg | 5 weeks | 11 |
| Zinc supplementation does not alter sensitive biomarkers of copper status in healthy boys 2013 · 5 mg zinc · Healthy boys aged 6–8 years | 5 mg | 122 days | 10 |
| The effect of calcium carbonate and calcium citrate on the absorption of zinc in healthy female subjects 1994 · Zinc alone · Healthy female university subjects | 4.5 mg | 1 day | 9 |
| Preliminary Comparison of Fractional Absorption of Zinc Sulphate, Zinc Gluconate, and Zinc Aspartate after Oral Supple-Mentation in Healthy Human Volunteers 2023 · 70Zn-Aspartate (Zn-Asp) · Healthy adults aged 25–50 years, four males and four females, with normal zinc status | 2 mg | 1 day | 8 |
| Preliminary Comparison of Fractional Absorption of Zinc Sulphate, Zinc Gluconate, and Zinc Aspartate after Oral Supple-Mentation in Healthy Human Volunteers 2023 · 70Zn-Sulfate hydrate (70ZnSO4) · Healthy adults aged 25–50 years, four males and four females, with normal zinc status | 2 mg | 1 day | 8 |
| Preliminary Comparison of Fractional Absorption of Zinc Sulphate, Zinc Gluconate, and Zinc Aspartate after Oral Supple-Mentation in Healthy Human Volunteers 2023 · 70Zn-Gluconate (Zn-Glu) · Healthy adults aged 25–50 years, four males and four females, with normal zinc status | 2 mg | 1 day | 8 |
| Effect of zinc on liver cirrhosis with hyperammonemia: a preliminary randomized, placebo-controlled double-blind trial 2014 · Z group · Patients with liver cirrhosis, hyperammonemia, and hypozincemia (≤65 μg/dL) | 150 mg | 90 days | 7 |
| The effect of five-year zinc supplementation on serum zinc, serum cholesterol and hematocrit in persons randomly assigned to treatment group in the age-related eye disease study: AREDS Report No. 7 2002 · antioxidants and zinc · Adults aged 55–80 years with early-to-late age-related macular degeneration | 80 mg | 5 years | — |
| Intestinal and systemic immune responses to an oral cholera toxoid B subunit whole-cell vaccine administered during zinc supplementation 2003 · zinc-supplemented vaccinees · adult zinc-replete volunteers | 135 mg | 9 days | — |
| Effect of oral zinc supplementation on agents of oropharyngeal infection in patients receiving radiotherapy for head and neck cancer 2003 · zinc group · Patients receiving radiotherapy for head and neck cancer | 150 mg | — | — |
| Impact of zinc supplementation on intestinal permeability in Bangladeshi children with acute diarrhoea and persistent diarrhoea syndrome 1992 · Zinc supplement, acute diarrhoea group · Children aged 3–24 months with acute diarrhoea | 5 mg/kg | 2 weeks | — |
| Impact of zinc supplementation on intestinal permeability in Bangladeshi children with acute diarrhoea and persistent diarrhoea syndrome 1992 · Zinc supplement, persistent diarrhoea group · Children aged 3–24 months with persistent diarrhoea | 5 mg/kg | 2 weeks | — |
| A moderately high intake compared to a low intake of zinc depresses magnesium balance and alters indices of bone turnover in postmenopausal women 2004 · Low dietary copper and high-zinc period · Postmenopausal women, mean age 64.9 years; no other condition stated | 53 mg | 90 days | — |
| A moderately high intake compared to a low intake of zinc depresses magnesium balance and alters indices of bone turnover in postmenopausal women 2004 · High dietary copper and high-zinc period · Postmenopausal women, mean age 64.9 years; no other condition stated | 53 mg | 90 days | — |
| Iron and/or zinc supplementation did not reduce blood lead concentrations in children in a randomized, placebo-controlled trial 2006 · Iron and zinc · First-grade children attending schools within 3.5 km of a metal foundry; lead-exposed | 30 mg | 26 weeks | — |
| Iron and zinc supplementation improved iron and zinc status, but not physical growth, of apparently healthy, breast-fed infants in rural communities of northeast Thailand 2006 · iron and zinc supplementation · Apparently healthy, breast-fed Thai infants aged 4–6 months | 10 mg | 26 weeks | — |
| Effects of long-term zinc supplementation on plasma thiol metabolites and redox status in patients with age-related macular degeneration 2007 · zinc · Adults aged 55–80 with age-related macular degeneration | 80 mg | 2433 days | — |
| The efficacy of micronutrient supplementation in reducing the prevalence of anaemia and deficiencies of zinc and iron among adolescents in Sri Lanka 2008 · iron+zinc group · Schoolchildren aged 12–16 years; the study reports a high prevalence of low iron stores, low serum zinc, and anaemia at baseline. | 14 mg | 24 weeks | — |
| Inflammation markers predict zinc transporter gene expression in women with type 2 diabetes mellitus 2013 · zinc plus ALA · postmenopausal women with type 2 diabetes mellitus | 40 mg | 12 weeks | — |
| Sensitivity of fatty acid desaturation and elongation to plasma zinc concentration: a randomised controlled trial in Beninese children 2018 · Zn-fortified filtered water · School-age children in Benin; sex and age range not specified | 2.8 mg | 20 weeks | — |
| Daily Preventive Zinc Supplementation Decreases Lymphocyte and Eosinophil Concentrations in Rural Laotian Children from Communities with a High Prevalence of Zinc Deficiency: Results of a Randomized Controlled Trial 2020 · daily preventive zinc tablets (PZ) · Children aged 6–23 months in rural Laotian communities with a high prevalence of zinc deficiency | 7 mg | 274 days | — |
| Daily Preventive Zinc Supplementation Decreases Lymphocyte and Eosinophil Concentrations in Rural Laotian Children from Communities with a High Prevalence of Zinc Deficiency: Results of a Randomized Controlled Trial 2020 · daily multiple micronutrient powder (MNP) · Children aged 6–23 months in rural Laotian communities with a high prevalence of zinc deficiency | 10 mg | 274 days | — |
| Effect of Oral Zinc Supplementation on Serum Bilirubin Levels in Term Neonates With Hyperbilirubinemia Undergoing Phototherapy: A Double-blind Randomized Controlled Trial 2023 · oral zinc sulfate · term neonates with jaundice within the phototherapy range | 5 mg | 5 days | — |
| Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration 2025 · AREDS zinc only · Adults aged 55–80 with early or more advanced age-related macular degeneration | 80 mg | 5 years | — |
| Effects of Zinc-Biofortified Wheat Intake on Plasma Markers of Fatty Acid Metabolism and Oxidative Stress Among Adolescents 2024 · zinc-biofortified wheat (ZBW) flour · Adolescent females aged 10–16 years in rural Khyber Pakhtunkhwa, Pakistan; the study population had a high prevalence of zinc deficiency | 1.5 mg | 25 weeks | — |
| Enteric protein loss and intestinal permeability changes in children during acute shigellosis and after recovery: effect of zinc supplementation 1994 · Vitamin B syrup with zinc acetate · Children aged 1–12 years with acute shigellosis | 15 mg/kg | 30 days | — |
| Zinc supplementation restores plasma concentrations of zinc and thymulin in patients with Crohn's disease 1993 · 200 mg/day ZnSO4 · Patients with Crohn's disease in clinical remission and decreased plasma zinc and active thymulin concentrations | 200 mg | 90 days | — |
| Including 60 mg Elemental Iron in a Multiple Micronutrient Supplement Blunts the Increase in Serum Zinc after 12 Weeks of Daily Supplementation in Predominantly Anemic, Nonpregnant Cambodian Women of Reproductive Age 2019 · MMN · Predominantly anemic, nonpregnant women aged 18–45 years | 15 mg | 12 weeks | 202 |
| The effects of a lipid-based nutrient supplement and antiretroviral therapy in a randomized controlled trial on iron, copper, and zinc in milk from HIV-infected Malawian mothers and associations with maternal and infant biomarkers 2018 · LNS · HIV-infected lactating women in Malawi | 19 mg | 28 weeks | 185 |
| Mineral status of non-anemic Peruvian infants taking an iron and copper syrup with or without zinc from 6 to 18 months of age: a randomized controlled trial 2013 · iron + copper + zinc group · Non-anemic Peruvian infants randomized at 6 months of age, born at term and weighing more than 2500 g; followed until 18 months | 10 mg | 1 year | 129 |
| Effect of zinc added to multi-vitamin supplementation containing low-dose vitamin A on plasma retinol level in children--a double-blind randomized, controlled trial 2007 · Vitamin A with zinc group · Children aged 5–36 months, including children with varied nutritional status | 10 mg | 120 days | 90 |
| The effects of a lipid-based nutrient supplement and antiretroviral therapy in a randomized controlled trial on iron, copper, and zinc in milk from HIV-infected Malawian mothers and associations with maternal and infant biomarkers 2018 · ARV + LNS · HIV-infected lactating women in Malawi | 19 mg | 28 weeks | 90 |
| Small-quantity lipid-based nutrient supplements containing different amounts of zinc along with diarrhea and malaria treatment increase iron and vitamin A status and reduce anemia prevalence, but do not affect zinc status in young Burkinabe children: a cluster-randomized trial 2017 · LNS-Zn10 · Children aged 9–10 months at enrollment, followed to 18 months; children with severe anemia, severe wasting, or illness requiring hospital referral were excluded. | 10 mg | 274 days | 79 |
| Small-quantity lipid-based nutrient supplements containing different amounts of zinc along with diarrhea and malaria treatment increase iron and vitamin A status and reduce anemia prevalence, but do not affect zinc status in young Burkinabe children: a cluster-randomized trial 2017 · LNS-Zn5 · Children aged 9–10 months at enrollment, followed to 18 months; children with severe anemia, severe wasting, or illness requiring hospital referral were excluded. | 5 mg | 274 days | 75 |
| Small-quantity lipid-based nutrient supplements containing different amounts of zinc along with diarrhea and malaria treatment increase iron and vitamin A status and reduce anemia prevalence, but do not affect zinc status in young Burkinabe children: a cluster-randomized trial 2017 · LNS-TabZn5 · Children aged 9–10 months at enrollment, followed to 18 months; children with severe anemia, severe wasting, or illness requiring hospital referral were excluded. | 5 mg | 274 days | 73 |
| Biofortified Yellow-Fleshed Potatoes Provide More Absorbable Zinc than a Commonly Consumed Variety: A Randomized Trial Using Stable Isotopes in Women in the Peruvian Highlands 2023 · Biofortified potato · Women aged 18–45 years living in Huancavelica, Peru, with BMI 18.5–25 kg/m²; some participants had low plasma zinc | 250 mcg | 1 day | 37 |
| Biofortified Yellow-Fleshed Potatoes Provide More Absorbable Zinc than a Commonly Consumed Variety: A Randomized Trial Using Stable Isotopes in Women in the Peruvian Highlands 2023 · Regular potato · Women aged 18–45 years living in Huancavelica, Peru, with BMI 18.5–25 kg/m²; some participants had low plasma zinc | 250 mcg | 1 day | 37 |
| Effect of exogenous phytase added to small-quantity lipid-based nutrient supplements (SQ-LNS) on the fractional and total absorption of zinc from a millet-based porridge consumed with SQ-LNS in young Gambian children: a randomized controlled trial 2019 · SQ-LNS with exogenous phytase · Children aged 18–23 months in The Gambia; asymptomatic, with some children stunted or wasted and none with low plasma zinc | 8 mg | 1 day | 30 |
| Effect of exogenous phytase added to small-quantity lipid-based nutrient supplements (SQ-LNS) on the fractional and total absorption of zinc from a millet-based porridge consumed with SQ-LNS in young Gambian children: a randomized controlled trial 2019 · SQ-LNS without exogenous phytase · Children aged 18–23 months in The Gambia; asymptomatic, with some children stunted or wasted and none with low plasma zinc | 8 mg | 1 day | 30 |
| Effect of NaFeEDTA-fortified soy sauce on zinc absorption in children 2015 · NaFeEDTA group · Children; age and health status not reported | 3 mg | — | 20 |
| Effect of NaFeEDTA-fortified soy sauce on zinc absorption in children 2015 · FeSO₄ group · Children; age and health status not reported | 3 mg | — | 20 |
| Effect of NaFeEDTA-fortified soy sauce on zinc absorption in children 2015 · control group · Children; age and health status not reported | 3 mg | — | 20 |
| Effect of Zinc Supplementation on GH, IGF1, IGFBP3, OCN, and ALP in Non-Zinc-Deficient Children 2015 · experimental group · Healthy, eutrophic children aged 8–9 years | 10 mg | 90 days | 20 |
| Folic acid enrichment of bread does not appear to affect zinc absorption in young women 2001 · B · Healthy women aged 22–33 years | 1.2 mg | 1 day | 15 |
| Folic acid enrichment of bread does not appear to affect zinc absorption in young women 2001 · C · Healthy women aged 22–33 years | 3 mg | 1 day | 15 |
| Folic acid enrichment of bread does not appear to affect zinc absorption in young women 2001 · D · Healthy women aged 22–33 years | 2.9 mg | 1 day | 15 |
| Prenatal iron supplements impair zinc absorption in pregnant Peruvian women 2000 · iron and zinc supplemented group (Fe + Zn) · Pregnant Peruvian women receiving prenatal supplements; studied in the third trimester | 15 mg | — | 14 |
| Low β-carotene bioaccessibility and bioavailability from high fat, dairy-based meal 2024 · β-carotene with zinc · Healthy men aged 18–45 years | 30 mg | 1 day | 12 |
| Iron supplements inhibit zinc but not copper absorption in vivo in ileostomy subjects 2003 · 100 mg Fe as ferrous gluconate · 11 adults with an ileostomy; mean age 55 ± 9 years; sex not specified | 12 mg | 1 day | 11 |
| Iron supplements inhibit zinc but not copper absorption in vivo in ileostomy subjects 2003 · 400 mg Fe as ferrous gluconate · 11 adults with an ileostomy; mean age 55 ± 9 years; sex not specified | 12 mg | 1 day | 11 |
| Zinc absorption in adult men from a chicken sandwich made with white or wholemeal bread, measured by a double-label stable-isotope technique 1992 · White-bread chicken sandwich · Fasted adult men | 2 mg | 1 day | 11 |
| Zinc absorption in adult men from a chicken sandwich made with white or wholemeal bread, measured by a double-label stable-isotope technique 1992 · Wholemeal-bread chicken sandwich · Fasted adult men | 2 mg | 1 day | 11 |
| Adding zinc to prenatal iron and folate supplements improves maternal and neonatal zinc status in a Peruvian population 1999 · Prenatal supplements with zinc · Pregnant women in a shantytown in Lima, Peru, beginning supplementation between gestation weeks 10 and 24 | 15 mg | — | — |
| Changes in iron status during pregnancy in peruvian women receiving prenatal iron and folic acid supplements with or without zinc 2000 · Iron, folic acid, and zinc · Pregnant women in Peru, from 10–24 weeks gestation to 4 weeks postpartum | 15 mg | — | — |
| Synergistic effect of zinc and vitamin A on the biochemical indexes of vitamin A nutrition in children 2002 · ZA group · Children aged 12–35 months; vitamin A-deficient children were a reported subgroup | 20 mg | 2 weeks | — |
| Cofortification of iron-fortified flour with zinc sulfate, but not zinc oxide, decreases iron absorption in Indonesian children 2002 · Iron-fortified flour with zinc oxide · Children aged 4–8 years in Indonesia | 60 mg/kg | 1 day | — |
| Cofortification of iron-fortified flour with zinc sulfate, but not zinc oxide, decreases iron absorption in Indonesian children 2002 · Iron-fortified flour with zinc sulfate · Children aged 4–8 years in Indonesia | 60 mg/kg | 1 day | — |
| Simultaneous weekly supplementation of iron and zinc is associated with lower morbidity due to diarrhea and acute lower respiratory infection in Bangladeshi infants 2003 · 20 mg elemental zinc with 1 mg riboflavin · Infants aged 6 months at enrollment, followed until 12 months | 2.86 mg | 183 days | — |
| Dose-response trial of prophylactic zinc supplements, with or without copper, in young Ecuadorian children at risk of zinc deficiency 2008 · 10 mg Zn + 0.5 mg Cu as copper sulfate · Ecuadorian children aged 12–30 months at baseline with length-for-age z scores below −1.3, at risk of zinc deficiency | 10 mg | 26 weeks | — |
| Plasma zinc concentration responds to short-term zinc supplementation, but not zinc fortification, in young children in Senegal1,2 2011 · ZnSuppl group · Children aged 9–17 months in Senegal | 6 mg | 15 days | — |
| Plasma zinc concentration responds to short-term zinc supplementation, but not zinc fortification, in young children in Senegal1,2 2011 · ZnFort group · Children aged 9–17 months in Senegal | 6 mg | 15 days | — |
| A longitudinal study of pyridoxine and zinc supplementation of lactating women 1990 · 0.5 mg pyridoxine, 25 mg zinc · Lactating women beginning 1 day postpartum | 25 mg | 39 weeks | — |
| A longitudinal study of pyridoxine and zinc supplementation of lactating women 1990 · 4.0 mg pyridoxine, 25 mg zinc · Lactating women beginning 1 day postpartum | 25 mg | 39 weeks | — |
| Iodine status of young Burkinabe children receiving small-quantity lipid-based nutrient supplements and iodised salt: a cluster-randomised trial 2015 · LNS with 10 mg Zn · children aged 9 to 18 months in Burkina Faso | 10 mg | 274 days | — |
| Effects of trace element and/or vitamin supplementation on vitamin and mineral status, free radical metabolism and immunological markers in elderly long term-hospitalized subjects. Geriatric Network MIN. VIT. AOX 1997 · trace elements · Institutionalized elderly subjects in long-term hospital or nursing-home care | 20 mg | 1 year | — |
| The impact of vitamin and/or mineral supplementation on lipid profiles in type 2 diabetes 2004 · group MV · Adults with type 2 diabetes; age and sex not reported | 30 mg | 90 days | 17 |
| Maternal B-vitamin and vitamin D status before, during, and after pregnancy and the influence of supplementation preconception and during pregnancy: Prespecified secondary analysis of the NiPPeR double-blind randomized controlled trial 2023 · intervention · Women planning pregnancy; generally healthy, recruited before conception | 10 mg | — | 870 |
| Antenatal Multiple Micronutrient Supplementation Compared to Iron-Folic Acid Affects Micronutrient Status but Does Not Eliminate Deficiencies in a Randomized Controlled Trial Among Pregnant Women of Rural Bangladesh 2019 · MM · Pregnant women aged 12–45 years in rural Bangladesh | 12 mg | 165 days | 749 |
| The impact of zinc and folic acid supplementation on sperm DNA methylation: results from the folic acid and zinc supplementation randomized clinical trial (FAZST) 2022 · FAZ group · Men aged 18 or older in couples seeking fertility treatment | 30 mg | 26 weeks | 713 |
| Including 60 mg Elemental Iron in a Multiple Micronutrient Supplement Blunts the Increase in Serum Zinc after 12 Weeks of Daily Supplementation in Predominantly Anemic, Nonpregnant Cambodian Women of Reproductive Age 2019 · Fe + MMN · Predominantly anemic, nonpregnant women aged 18–45 years | 15 mg | 12 weeks | 206 |
| Newborn micronutrient status biomarkers in a cluster-randomized trial of antenatal multiple micronutrient compared with iron folic acid supplementation in rural Bangladesh 2020 · MM · Pregnant women in rural Bangladesh; age range not specified; no disease condition specified | 12 mg | — | 176 |
| Effect of supplementation with a lipid-based nutrient supplement on the micronutrient status of children aged 6-18 months living in the rural region of Intibucá, Honduras 2014 · intervention group · Children enrolled at 5–18 months of age, living in rural Intibucá, Honduras, without stated medical conditions | 27 mg | 1 year | 160 |
| Effect of oral zinc supplementation on copper and haemoglobin levels in pregnant women 1994 · Gp B (zinc treated group) · Pregnant women in different trimesters of pregnancy | 45 mg | — | 104 |
| Compliance with home-based fortification strategies for delivery of iron and zinc: its effect on haematological and growth markers among 6-24 months old children in north India 2014 · Rice-fortified complementary food and nutrition education (Cf) · Children aged 6–24 months in North Delhi, India; children were not selected for a diagnosed condition or documented nutrient deficiency. | 6.5 mg | 26 weeks | 101 |
| Weekly iron supplementation does not block increases in serum zinc due to weekly zinc supplementation in Bangladeshi infants 2005 · 1 mg riboflavin + 20 mg iron and 20 mg zinc · 6-month-old Bangladeshi infants | 2.86 mg | 26 weeks | 85 |
| mRNA Levels of Placental Iron and Zinc Transporter Genes Are Upregulated in Gambian Women with Low Iron and Zinc Status 2017 · MMN group · Pregnant women aged 18–45 years with singleton pregnancies under 20 weeks in rural Gambia | 30 mg | 184 days | 75 |
| mRNA Levels of Placental Iron and Zinc Transporter Genes Are Upregulated in Gambian Women with Low Iron and Zinc Status 2017 · PE+MMN group · Pregnant women aged 18–45 years with singleton pregnancies under 20 weeks in rural Gambia | 30 mg | 184 days | 75 |
| Red blood cell metallothionein as an indicator of zinc status during pregnancy 2008 · supplement with zinc · Pregnant women in coastal Peru, enrolled at 10–16 weeks gestation and considered low risk, carrying a singleton fetus | 25 mg | — | 72 |
| Double-blind, placebo-controlled trial comparing effects of supplementation with two different combinations of micronutrients delivered as sprinkles on growth, anemia, and iron deficiency in cambodian infants 2006 · MMN · Infants aged 6 months living in Kompong Chhnang Province, Cambodia | 5 mg | 1 year | 68 |
| Double-blind, placebo-controlled trial comparing effects of supplementation of two micronutrient sprinkles on fatty acid status in Cambodian infants 2007 · mineral/micronutrient (MMN) · Cambodian infants aged 6 months at enrolment | 5 mg | 1 year | 68 |
| Effects of Multivitamin, Multimineral and Phytonutrient Supplementation on Nutrient Status and Biomarkers of Heart Health Risk in a Russian Population: A Randomized, Double Blind, Placebo Controlled Study 2018 · VMP (Nutrilite Double X™) · Generally healthy adults aged 40–70 years in Moscow with low habitual recommended-food intake (recommended food score <12), predominantly women; no chronic diseases | 6 mg | 8 weeks | 60 |
| Trace element supplementation in hemodialysis patients: a randomized controlled trial 2015 · medium dose · Adults aged 18 years or older on maintenance hemodialysis, with end-stage kidney disease | 50 mg | 180 days | 52 |
| The effect of zinc lactate and magnolia bark extract added tablets on volatile sulfur-containing compounds in the oral cavity 2014 · test group · Adults, men and women, without reported oral or systemic disease and with baseline oral VSC ≥75 ppb | 170 mcg | 1 day | 50 |
| Trace element supplementation in hemodialysis patients: a randomized controlled trial 2015 · low dose · Adults aged 18 years or older on maintenance hemodialysis, with end-stage kidney disease | 25 mg | 180 days | 47 |
| An Animal-Source Food Supplement Increases Micronutrient Intakes and Iron Status among Reproductive-Age Women in Rural Vietnam 2017 · ASF group · Women aged 18–30 years, nonpregnant, of reproductive age in rural Vietnam | 2.7 mg | 26 weeks | 47 |
| Randomized Study of the Effects of Zinc, Vitamin A, and Magnesium Co-supplementation on Thyroid Function, Oxidative Stress, and hs-CRP in Patients with Hypothyroidism 2021 · intervention group · Adults aged 20–65 with hypothyroidism | 30 mg | 10 weeks | 43 |
| Efficacy of different strategies to treat anemia in children: a randomized clinical trial 2010 · Multiple micronutrients supplement (MMS) · Children aged 6–42 months with anemia in rural communities in Mexico | 5.6 mg | 120 days | 36 |
| Micronutrient deficiency in obese subjects undergoing low calorie diet 2012 · LCD intervention group (low-calorie formula diet) · Adults with obesity (BMI ≥30 kg/m²), men and women; age approximately 47 years on average | 15 mg | 12 weeks | 32 |
| The Effects of Magnesium and Zinc Co-Supplementation on Biomarkers of Inflammation and Oxidative Stress, and Gene Expression Related to Inflammation in Polycystic Ovary Syndrome: a Randomized Controlled Clinical Trial 2018 · Magnesium and zinc co-supplementation · Women aged 18–40 with polycystic ovary syndrome diagnosed according to the Rotterdam criteria | 440 mg | 12 weeks | 30 |
| Effect of zinc supplementation on immune and inflammatory responses in pediatric patients with shigellosis 2004 · zinc group · Children aged 12–59 months with Shigella infection, acute shigellosis, and moderate malnutrition | 20 mg | 2 weeks | 28 |
| Effects of zinc supplementation as adjunct therapy on the systemic immune responses in shigellosis 2005 · zinc group · Children aged 12–59 months with Shigella flexneri infection and mild to moderate malnutrition | 20 mg | 2 weeks | 28 |
| The effect of zinc and vitamin E cosupplementation on metabolic status and its related gene expression in patients with gestational diabetes 2019 · Zinc gluconate plus vitamin E · Women aged 18–40 with gestational diabetes mellitus | 233 mg | 6 weeks | 27 |
| The effects of combined magnesium and zinc supplementation on metabolic status in patients with type 2 diabetes mellitus and coronary heart disease 2020 · Magnesium plus zinc group · Women aged 40–95 with type 2 diabetes mellitus and proven two- or three-vessel coronary heart disease | 150 mg | 12 weeks | 27 |
| Effects of branched-chain amino acids and zinc-enriched nutrients on prognosticators in HCV-infected patients: a multicenter randomized controlled trial 2015 · supplement group · HCV-infected patients | 10 mg | 60 days | 26 |
| High 15-F2t-Isoprostane Levels in Patients with a Previous History of Nonmelanoma Skin Cancer: The Effects of Supplementary Antioxidant Therapy 2015 · supplemented group · Adults aged 20 years or older with a previous history of nonmelanoma skin cancer treated by surgery | 50 mg | 60 days | 26 |
| Effect of Supplementation of a Butyrate-Based Formula in Individuals with Liver Steatosis and Metabolic Syndrome: A Randomized Double-Blind Placebo-Controlled Clinical Trial 2024 · Active treatment · Adults with ultrasound-diagnosed liver steatosis and metabolic syndrome | 10 mg | 12 weeks | 25 |
| Bioavailability of AREDS1 micronutrients from softgel capsules and tablets: a pilot study 2014 · softgel half-dose (single softgel) · Healthy adults aged 18–45 years, women and men | 34.8 mg | 1 day | 15 |
| Bioavailability of AREDS1 micronutrients from softgel capsules and tablets: a pilot study 2014 · softgel full-dose (two softgels) · Healthy adults aged 18–45 years, women and men | 69.6 mg | 1 day | 15 |
| Bioavailability of AREDS1 micronutrients from softgel capsules and tablets: a pilot study 2014 · tablet full-dose (four tablets) · Healthy adults aged 18–45 years, women and men | 69.6 mg | 1 day | 15 |
| Zinc absorption from micronutrient powder is low but is not affected by iron in Kenyan infants 2014 · MNP + Fe · Breastfed infants enrolled just before 6 months of age and followed to approximately 9 months; healthy, with hemoglobin ≥10 g/dL and no malaria parasites at enrollment | 5 mg | 90 days | 15 |
| Zinc absorption from micronutrient powder is low but is not affected by iron in Kenyan infants 2014 · MNP − Fe · Breastfed infants enrolled just before 6 months of age and followed to approximately 9 months; healthy, with hemoglobin ≥10 g/dL and no malaria parasites at enrollment | 5 mg | 90 days | 15 |
| Effect of probiotic L. plantarum IS-10506 and zinc supplementation on humoral immune response and zinc status of Indonesian pre-school children 2014 · combination of probiotic and zinc · Indonesian children aged 12–24 months | 20 mg | 90 days | 12 |
| Zinc supplementation prevents the increase of transaminase in chronic hepatitis C patients during combination therapy with pegylated interferon alpha-2b and ribavirin 2007 · zinc group · Patients with chronic hepatitis C receiving pegylated interferon alpha-2b and ribavirin therapy | 150 mg | 48 weeks | 11 |
| The effect of calcium carbonate and calcium citrate on the absorption of zinc in healthy female subjects 1994 · Zinc with calcium carbonate · Healthy female university subjects | 4.5 mg | 1 day | 9 |
| The effect of calcium carbonate and calcium citrate on the absorption of zinc in healthy female subjects 1994 · Zinc with calcium citrate · Healthy female university subjects | 4.5 mg | 1 day | 9 |
| Treatment for iron deficiency anaemia with a combined supplementation of iron, vitamin A and zinc in women of Dinajpur, Bangladesh 1999 · Group C (iron, vitamin A and zinc) · Non-pregnant women aged 15–45 years with anaemia and haemoglobin ≤100 g/L | 15 mg | 60 days | — |
| Influence of selenium supplements on the post-traumatic alterations of the thyroid axis: a placebo-controlled trial 2001 · Selenium with alpha-tocopherol and zinc · Critically ill trauma patients, mean age 42 years, with severe multiple injury | 13 mg | 5 days | — |
| Effect of two years' supplementation with natural antioxidants on vitamin and trace element status biomarkers: preliminary data of the SU.VI.MAX study 2001 · Antioxidant supplementation group · Women aged 35–60 years and men aged 45–60 years in France, general population | 20 mg | 2 years | — |
| Changes in serum retinol, alpha-tocopherol, vitamin C, carotenoids, xinc and selenium after micronutrient supplementation during alcohol rehabilitation 2003 · micronutrient supplement group · Alcohol-dependent patients aged 20 to 60 years without severe liver disease, hospitalized for alcohol rehabilitation | 20 mg | 3 weeks | — |
| Randomized controlled trial of prenatal zinc supplementation and fetal bone growth 2004 · supplements containing 60 mg Fe and 250 microg folic acid, with 25 mg Zn · Pregnant women in Peru, enrolled at 10–16 weeks of gestation | 25 mg | — | — |
| A moderately high intake compared to a low intake of zinc depresses magnesium balance and alters indices of bone turnover in postmenopausal women 2004 · Low dietary copper and low-zinc period · Postmenopausal women, mean age 64.9 years; no other condition stated | 3 mg | 90 days | — |
| A moderately high intake compared to a low intake of zinc depresses magnesium balance and alters indices of bone turnover in postmenopausal women 2004 · High dietary copper and low-zinc period · Postmenopausal women, mean age 64.9 years; no other condition stated | 3 mg | 90 days | — |
| Zinc plus beta-carotene supplementation of pregnant women is superior to beta-carotene supplementation alone in improving vitamin A status in both mothers and infants 2004 · beta-carotene plus zinc · Pregnant women; age and specific condition not stated | 30 mg | — | — |
| Short-term daily or weekly administration of micronutrient Sprinkles has high compliance and does not cause iron overload in Chinese schoolchildren: a cluster-randomised trial 2006 · daily group · Children aged 3–6 years in a kindergarten in northern China | 5 mg | 13 weeks | — |
| Effects of combination of zinc and vitamin A supplementation on serum fasting blood sugar, insulin, apoprotein B and apoprotein A-I in patients with type I diabetes 2010 · zinc and vitamin A (VAZ)-supplemented · Males and females aged 7–20 with type I diabetes for at least 2 years | 10 mg | 12 weeks | — |
| Community-level micronutrient fortification of school lunch meals improved vitamin A, folate, and iron status of schoolchildren in Himalayan villages of India 2010 · multiple micronutrients (treatment group) · Schoolchildren aged 6–10 years in Himalayan villages of India | 4.2 mg | 240 days | — |
| Plasma zinc concentration increases within 2 weeks in healthy Senegalese men given liquid supplemental zinc, but not zinc-fortified wheat bread 2011 · zinc supplement · Healthy Senegalese men aged 18 years or older | 15 mg | 4 weeks | — |
| Plasma zinc concentration increases within 2 weeks in healthy Senegalese men given liquid supplemental zinc, but not zinc-fortified wheat bread 2011 · moderate zinc fortification · Healthy Senegalese men aged 18 years or older | 7.5 mg | 4 weeks | — |
| Plasma zinc concentration increases within 2 weeks in healthy Senegalese men given liquid supplemental zinc, but not zinc-fortified wheat bread 2011 · high zinc fortification · Healthy Senegalese men aged 18 years or older | 15 mg | 4 weeks | — |
| Patterns of compliance with prenatal iron supplementation among Peruvian women 2014 · Iron, folate, and zinc · Pregnant women enrolled at 10–24 weeks of gestation and followed through 4 weeks postpartum | 15 mg | — | — |
| Effect of zinc and vitamin A supplementation on immune responses in Indonesian pre-schoolers 2020 · zinc plus vitamin A · Indonesian preschool children aged 2–5 years | 10 mg | 120 days | — |
| Efficacy of myo-inositol and zinc on insulin resistance in a paediatric population with obesity 2025 · TRT · Patients aged 10–18 years with obesity and insulin resistance | 5 mg | 90 days | — |
| Effect of 6 month supplementation with different combinations of an association of antioxidant nutrients on biochemical parameters and markers of the antioxidant defence system in the elderly. The Geriatrie/Min.Vit.Aox Network 1996 · VT (vitamins associated with trace elements) · Elderly nursing-home residents aged 65–103 years who were long-term hospitalized | 20 mg | 26 weeks | — |
| Zinc supplementation and plasma lipid peroxides in an elderly population 1997 · vitamin A and zinc · elderly residents of a public home in Rome, described as healthy | 25 mg | 90 days | — |
| Effect of a two-year supplementation with low doses of antioxidant vitamins and/or minerals in elderly subjects on levels of nutrients and antioxidant defense parameters 1997 · mineral and vitamin group · Hospitalized adults older than 65 years; baseline deficiencies of vitamin C, zinc and selenium were common | 20 mg | 2 years | — |
| Effects of trace element and/or vitamin supplementation on vitamin and mineral status, free radical metabolism and immunological markers in elderly long term-hospitalized subjects. Geriatric Network MIN. VIT. AOX 1997 · trace elements associated with vitamins · Institutionalized elderly subjects in long-term hospital or nursing-home care | 20 mg | 1 year | — |
| Effects of supplementation with a combination of antioxidant vitamins and trace elements, at nutritional doses, on biochemical indicators and markers of the antioxidant system in adult subjects 1998 · supplementation group · Adult men aged 45–60 years and women aged 35–60 years | 20 mg | 26 weeks | — |
| Micronutrient supplements can promote disruptive protozoan and fungal communities in the developing infant gut 2021 · MNP with zinc · Children enrolled at 6 months of age in Pakistan; included undernourished and reference weight-for-length groups | 10 mg | 1 year | 889 |
| Impact of micronutrient fortification of yoghurt on micronutrient status markers and growth - a randomized double blind controlled trial among school children in Bangladesh 2013 · Fortified yoghurt (FY group) · Children aged 6–9 years attending primary schools in rural Bangladesh; boys and girls, with a high prevalence of anemia and suboptimal micronutrient status | 3 mg | 1 year | 501 |
| Micronutrient Sprinkles reduce anemia among 9- to 24-mo-old children when delivered through an integrated health and nutrition program in rural Haiti 2007 · Sprinkles-WSB (S-WSB) · Children aged 9–24 months in rural Haiti receiving take-home fortified wheat-soy blend rations | 5 mg | 60 days | 254 |
| Multiple micronutrient supplementation improves micronutrient status in primary school children in Hai Phong City, Vietnam: a randomised controlled trial 2021 · intervention · Children aged 6–9 years, apparently healthy, in rural Hai Phong City, Vietnam; included undernourished, normal-weight, and overweight/obese children | 10 mg | 22 weeks | 175 |
| Effect of daily and weekly micronutrient supplementation on micronutrient deficiencies and growth in young Vietnamese children 1999 · daily group · children aged 6–24 months in Vietnam | 5 mg | 90 days | 55 |
| A Clinical Trial about a Food Supplement Containing α-Lipoic Acid on Oxidative Stress Markers in Type 2 Diabetic Patients 2016 · food supplement containing α-lipoic acid · Caucasian adults aged 18–75 years, both sexes, with overweight and type 2 diabetes and HbA1c >7.0% | 7.5 mg | 90 days | 54 |
| Effect of daily and weekly micronutrient supplementation on micronutrient deficiencies and growth in young Vietnamese children 1999 · weekly group · children aged 6–24 months in Vietnam | 2.43 mg | 90 days | 54 |
| Nutraceutical approaches to homocysteine lowering in hypertensive subjects at low cardiovascular risk: a multicenter, randomized clinical trial 2016 · Normocis 400® group · Adults with stage 1 essential hypertension and hyper-homocysteinemia (HCys ≥15 μmol/L), without a history of cardiovascular or cerebrovascular disease; mean age 62.8 years, 63.5% male | 12.5 mg | 60 days | 52 |
| Effects of Perioperative Zinc Supplementation on Copper Circulating Levels and Expression of Metallothionein and Copper Antioxidant Chaperone-1 in Leukocytes in Patients Undergoing CABG Surgery 2025 · zinc-vitamin E group · Patients undergoing coronary artery bypass graft (CABG) surgery; age and sex not specified | 150 mg | 22 days | 40 |
| Zinc increases the effects of essential amino acids-whey protein supplements in frail elderly 2009 · EAA / whey protein with zinc (30mg/d) · Undernourished hospitalized adults aged 66.7–105.8 years, both sexes; mean age 83.6 years | 30 mg | 4 weeks | 30 |
| A Trial on The Effects of Magnesium-Zinc-Calcium-Vitamin D Co-Supplementation on Glycemic Control and Markers of Cardio-Metabolic Risk in Women with Polycystic Ovary Syndrome 2017 · Magnesium-zinc-calcium-vitamin D co-supplementation · Women with polycystic ovary syndrome (PCOS) | 8 mg | 12 weeks | 30 |
| The effects of magnesium-zinc-calcium-vitamin D co-supplementation on biomarkers of inflammation, oxidative stress and pregnancy outcomes in gestational diabetes 2019 · Magnesium-zinc-calcium-vitamin D group · Women aged 18–40 with gestational diabetes mellitus, at 24–28 weeks’ gestation at diagnosis | 8 mg | 6 weeks | 30 |
| Efficacy and Tolerability of a Food Supplement Based on Zea mays L., Gymnema sylvestre (Retz.) R.br.ex Sm, Zinc and Chromium for the Maintenance of Normal Carbohydrate Metabolism: A Monocentric, Randomized, Double-Blind, Placebo-Controlled Clinical Trial 2024 · Group 1 (two FS tablets) · Adults aged 18–75 years, either sex, with mildly impaired fasting blood glucose (98–125 mg/dL) | 15 mg | 90 days | 27 |
| Effect and Tolerability of a Nutritional Supplement Based on a Synergistic Combination of β-Glucans and Selenium- and Zinc-Enriched Saccharomyces cerevisiae (ABB C1(®)) in Volunteers Receiving the Influenza or the COVID-19 Vaccine: A Randomized, Double-Blind, Placebo-Controlled Study 2021 · ABB C1® group, COVID-19-vaccine cohort · Men and women aged 18 years or older receiving COVID-19 vaccine, recruited from long-stay centers or as healthcare workers at the study centers | 15 mg | 5 weeks | 18 |
| Comparison of the effects of vitamins and/or mineral supplementation on glomerular and tubular dysfunction in type 2 diabetes 2005 · group MV · Patients with type 2 diabetes; age range and sex not specified | 30 mg | 90 days | 17 |
| Oxidative stress in humans during work at moderate altitude 1999 · antioxidant mixture group · U.S. Marines engaged in moderate-altitude cold-weather field training; age and sex not reported | 30 mg | 4 weeks | 15 |
| Effect and Tolerability of a Nutritional Supplement Based on a Synergistic Combination of β-Glucans and Selenium- and Zinc-Enriched Saccharomyces cerevisiae (ABB C1(®)) in Volunteers Receiving the Influenza or the COVID-19 Vaccine: A Randomized, Double-Blind, Placebo-Controlled Study 2021 · ABB C1® group, influenza-vaccine cohort · Men and women aged 60 years or older receiving influenza vaccine and requiring hospitalization or ambulatory follow-up by palliative support teams | 15 mg | 30 days | 14 |
| Omega-3 supplementation combined with anti-vascular endothelial growth factor lowers vitreal levels of vascular endothelial growth factor in wet age-related macular degeneration 2014 · Group 1 (Vitalux plus Omega-3) · Adults with active wet age-related macular degeneration who had previously received anti-VEGF treatment | 25 mg | — | 10 |
| Multinutrient Supplementation Increases Collagen Synthesis during Early Wound Repair in a Randomized Controlled Trial in Patients with Inguinal Hernia 2020 · multinutrient group · Men scheduled for Lichtenstein inguinal hernia repair; mean age 55.2 years, with inguinal hernia disease | 55 mg | 4 weeks | 10 |
| Effect of antioxidant supplementation on urine and blood markers of oxidative stress during extended moderate-altitude training 1999 · antioxidant supplement (S) group · US Marine Corps volunteers undergoing 14 days of winter training at approximately 2700 m | 30 mg | 2 weeks | — |
| Prophylactic iron supplementation in pregnant women in Norway 2001 · 15 mg iron daily · Non-anaemic pregnant women, allocated at about 10 weeks of pregnancy | 10 mg | — | — |
| Supplementation with micronutrients in addition to iron and folic acid does not further improve the hematologic status of pregnant women in rural Nepal 2003 · folic acid plus iron and zinc · Pregnant women in rural Nepal | 30 mg | — | — |
| Supplementation with micronutrients in addition to iron and folic acid does not further improve the hematologic status of pregnant women in rural Nepal 2003 · folic acid plus iron, zinc and multiple micronutrients · Pregnant women in rural Nepal | 30 mg | — | — |
| Alterations of the lipid profile after 7.5 years of low-dose antioxidant supplementation in the SU.VI.MAX Study 2005 · antioxidant supplementation · French adults: women aged 35–60 years and men aged 45–60 years | 20 mg | 2738 days | — |
| Effects of long-term zinc supplementation on plasma thiol metabolites and redox status in patients with age-related macular degeneration 2007 · antioxidants plus zinc · Adults aged 55–80 with age-related macular degeneration | 80 mg | 2433 days | — |
| Antioxidant micronutrients and biomarkers of oxidative stress and inflammation in colorectal adenoma patients: results from a randomized, controlled clinical trial 2010 · antioxidant micronutrient combination · Patients with a history of sporadic colorectal adenoma; age and sex not specified | 60 mg | 120 days | — |
| Differential effects of calcium- and vitamin D-fortified milk with FOS-inulin compared to regular milk, on bone biomarkers in Chinese pre- and postmenopausal women 2016 · Intervention (Int), premenopausal women · Premenopausal women, mean age 41 years; no specific condition stated | 2.4 mg | 12 weeks | — |
| Differential effects of calcium- and vitamin D-fortified milk with FOS-inulin compared to regular milk, on bone biomarkers in Chinese pre- and postmenopausal women 2016 · Intervention (Int), postmenopausal women · Postmenopausal women, mean age 59 years; no specific condition stated | 2.4 mg | 12 weeks | — |
| Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration 2025 · AREDS antioxidants plus zinc · Adults aged 55–80 with early or more advanced age-related macular degeneration | 80 mg | 5 years | — |
| Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration 2025 · AREDS2 original AREDS formulation · Adults aged 50–85 with large drusen in both eyes or late AMD in one eye and large drusen in the fellow eye who accepted the additional AREDS formulation | 80 mg | 5 years | — |
| Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration 2025 · AREDS2 original AREDS formulation without β-carotene · Adults aged 50–85 with large drusen in both eyes or late AMD in one eye and large drusen in the fellow eye who accepted the additional AREDS formulation | 80 mg | 5 years | — |
| Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration 2025 · AREDS2 original AREDS formulation with low zinc · Adults aged 50–85 with large drusen in both eyes or late AMD in one eye and large drusen in the fellow eye who accepted the additional AREDS formulation | 25 mg | 5 years | — |
| Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration 2025 · AREDS2 original AREDS formulation without β-carotene and with low zinc · Adults aged 50–85 with large drusen in both eyes or late AMD in one eye and large drusen in the fellow eye who accepted the additional AREDS formulation | 25 mg | 5 years | — |
| Redistribution of vitamin A after iron supplementation in Indonesian infants 2003 · 10 mg each of Fe and Zn · Indonesian infants aged 4 months | 10 mg | 26 weeks | — |
| Redistribution of vitamin A after iron supplementation in Indonesian infants 2003 · 10 mg Zn + 2.4 mg beta-carotene · Indonesian infants aged 4 months | 10 mg | 26 weeks | — |